Medical publications - Biomapilot Viscchini Enzymes

Size: px
Start display at page:

Download "Medical publications - Biomapilot Viscchini Enzymes"

Transcription

1 II uii IIi US B2 (12) United States Patent Pavlakis (10) Patent No.: US 7,608,422 B2 (45) Date of Patent: Oct. 27, 2009 (54) SIMIAN IMMUNODEFICIENCY VIRUS (SIV) MOLECULAR CLONE ENCODING MUTANT GAG GENE LACKING INHIBITORY/INSTABILITY REGIONS (75) Inventor: George N. Pavlakis, Rockville, MD (US) (73) Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Washington, DC (US) (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 U.S.C. 154(b) by 962 days. (21) Appl. No.: 10/644,027 (22) Filed: Aug. 19, 2003 (65) Prior Publication Data US 2004/ Al Apr. 22, 2004 Related U.S. Application Data (60) Division of application No. 09/872,733, filed on Jun. 1, 2001, now Pat. No. 6,656,706, which is a continuationin-part of application No. PCT/US00/34985, filed on Dec. 22, (60) Provisional application No. 60/173,036, filed on Dec. 23, (51) Int. Cl. C12P 21/06 ( ) C07H 21/04 ( ) C12N 15/00 ( ) C12N 5/00 ( ) (52) U.S. Cl /69.1; 435/325; 435/455; 536/23.72; 514/44 (58) Field of Classification Search... None See application file for complete search history. (56) References Cited U.S. PATENT DOCUMENTS 5,786,464 A 7/1998 Seed et al. 5,795,737 A 8/1998 Seed 5,965,726 A * 10/1999 Pavlakis et al / ,972,596 A 10/1999 Pavlakis et al. 6,114,148 A 9/2000 Seed et al. 6,174,666 B1 1/2001 Pavlakis et al. OTHER PUBLICATIONS Myers, G., et al., Human Retroviruses and AIDS 1995: A compilation and analysis of nucleic acid and amino acid sequences, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, section IB (HIV-2/SIV gag nucleotide sequence alignment).* Benson, J., et al., 1998, Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SlVmac251: dependence on route of challenge exposure, J. Virol. 72(5): * * cited by examiner Primary Examiner Jeffrey S. Parkin (74) Attorney, Agent, or Firm Townsend and Townsend and Crew LLP (57) ABSTRACT Nucleic acid constructs containing HIV-1 gag/pol and SIV gag or SIV env genes which have been mutated to remove or reduce inhibitory/instability sequences are disclosed. Viral particles and host cells containing these constructs and/or viral particles are also disclosed. The exemplified constructs and viral particles of the invention may be useful in gene therapy for numerous disorders, including HIV infection, or as a vaccine for HIV- 1 immunotherapy and immunoprophylaxis. 8 Claims, 45 Drawing Sheets

2 U.S. Patent Oct. 27, 2009 Sheet 1 of 45 US 7,608,422 B2 ATGGGTGCGAGAGCGTCAGTATTAAGCGGGGGAGAATTAGATCGATGGGAUUU%AT TCGGTTAAGGCCAGGGGGAAAGAAGAAGTACAAGCTAAAGCACATCGTATGGGCAA GCAGGGAGCTAGAACGATTCGCAGTTAATCCTGGCCTGTTAGAAACATCAGAAGGC TGTAGACAAATACTGGGACAGCTACAACCATCCCTTCAGACAGGATCAGAḠGAGCT TCGATCACTATACAACACAG TAG CAACCCTC TAT TGTGTGCACCAGCGGATCGAGA TCAAGGACACCAAGGAAGCTTTAGACAAGATAGAGGAAGAGCAAAACAAGTCCAAG AAGAAGGCCCAGCAGGCAGCAGCTGACACAGGACACAGCAATCAGGTCAGCCAAAA TTACCCTATAGTGCAGAACATCCAGGGGCAAATGGTACATCAGGCCATATCACCTA CAACTTTAAATGCATGGGTAAAAGTAGTAGAAGAGAAGGCTTTCAGCCCAGAAGTG ATACCCATGTTTTCAGCATTATCAGAAGGAGCCACCCCACAGGACCTGAACACGAT GTTGAACACCGTGGGGGGACATCAAGCAGCCATGCAAATGTTAAAAGAGACCATCA ATGAGGAAGCTGCAGAATGGGATAGAGTGCATCCAGTGCATGCAGGGCCTATTGCA CCAGGCCAGATGAGAGAACCAAGGGGAAGTGACATAGCAGGAACTACTAGTACCCT TCAGGAACAAATAGGATGGATGACAAATAATCCACCTATCCCAGTAGGAGAGATCT P.CAAGAGGTGGATAATCCTGGGATTGAACAAGATCGTGAGGATGTATAGCCCTACC AGCATTCTGGACATAAGACAAGGACCAAAGGAACCCTTTAGAGACTATGTA-GACCG GTTCTATAAAACTCTAAGAGCTGAGCAAGCTTCACAGGAGGTAAA.AAATTGGATGA CAGAAACCTTGTTGGTCCAAAATGCGAA-CCCAGATTGTAAGACCATCCTGAAGGCT CTCGGCCCAGCGGCTACACTAGAAGAAATGATGACAGCATGTCAGGGAGTAGGAGG ACCCGGCCATAAGGCAAGAGTTTTGGCCGAGGCGATGAGCCAGGTGACGAACTCGG CGP_CCATAATGATGCAGAGAGGCAACTTCCGGAACCAGCGCAAGATCGTCAAGTGC TTCAATTGTGGCAAAGAAGGGCACACCGCCAGGAACTGCCGGGCCCCGCGGAT AA GGGCTGTTGGAAATGTGGAAAGGAAGGACACCAAATGAAAGATTGTACTGAGAGAC FIG. IA

3 U.S. Patent Oct. 27, 2009 Sheet 2 of 45 US 7,608,422 B2 AGGCTAATTTTTTAGGGAAGATCTGGCCTTCCTACAAGGGAAGGCCAGGGAATTTT CTTCAGAGCAGACCAGAGCCAACAGCCCCACCAGAAGAGAGCTTCAGGTCTGGGGT AGAGACAACAACTCCCCCTCAGAAGCAGGAGCCGATAGACAAGGAACTGTATCCTT TAACTTCCCTCAGATCACTCTTTGGCAACGACCCCTCGTCACAGTAAGGATCGGGG GGCAACTCAAGGAAGCGCTGCTC GATACAGGAGCAGATGATACAGTATTAGAAGAA ATGAGTTTGCCAGGAAGATGGAAACCAAAAATGATAGGGGGGATCGCGGGCTTCAT CAAGGTGAGGCAGTACGACCAGATACTCATAGAAATCTCTGGACATAAAGCTATAG GTACAGTATTAGTAGGACCTACACCTGTCAACATAATTGGAAGAAATCTGTTGACC CAGGATCGGCTGCACCTTGAACTTCCCCATCAGCCCTATTGAGACGGTGCCCGTGAA GTTGAAGCCGGGGATGGACGGCCCCAAGGTCAAGCAATGGCCATTGACGAAAGAGA AGATCAAGGCCTTAGTCGAAATCTGTACAGAGATGGAGAAGGAAGGGAAGATCAGC AAGATCGGGCCTGAGAACCCCTACAACACTCCAGTCTTCGCAATCAAGAAGAAGGA CAGTACCAAGTGGAGAAAGCTGGTGGACTTCAGAGAGCTGAACAAGAGAACTCAGG ACTTCTGGGAAGTTCAGCTGGGCATCCCACATCCCGCTGGGTTGAAGAAGAAGAAG TCAGTGACAGTGCTGGATGTGGGTGATGCCTACTTCTCCGTTCCCTTGGACGAGGA CTTCAGGAAGTACACTGCCTTCACGATACCTAGCATCAACAACGAGACACCAGGCA TCCGCTACCAGTACAACGTGCTGCCACAGGGATGGAAGGGATCA-CCAGCCATCTTT CAAAGCAGCATGACCAAGATCCTGGAGCCCTTCCGCAAGCAAAACCCAGACATCGT GATCTATCAGTACATGGGACGACCTCTAGGTAGGAAGTGACCTGGAGATCGGGCAGC ACAGGACCAAGATCGAGGAGCTGAGACAGCATCTGTTGAGGTGGGGACTGACCACA CCAGACAAGAAGCACCAGAAGGAACCTCCCTTCCTGTGG4TGGGCTACGAACTGCA TCCTGACAAGTGGACAGTGCAGCCCAT-CGTCTGCCTGAGAAGGACAGCTGGACTG TG..ACGACATACAGAAGCTCGTGGGCAAGTTGAACTCiGGCAAGCCAGATCTACCCA GGCATCAAAGTTAGGCAGCTGTGCAAGCTGCTTCGAGGAACCAAGGCACTGACAGA FIG. IB

4 U.S. Patent Oct. 27, 2009 Sheet 3 of 45 US 7,608,422 B2 AGTGATCCCACTGACAGAGGAAGCAGAGCTAGAACTGGCAGAGAACCGA,GAGATCC TGAAGGAGCCAGTACATGGAGTGTACTACGACCCAAGCAAGGACCTGATCGCAGAG ATCCAGAAGCAGGGGCAAGGCCAATGGACCTACCAAATCTACCAGGAGCCCTTCAA GAACCTGAAGACAGGCAAGTACGCAAGGATGAGGGGTGCCCACACCAACGATGTGA AGCAGCTGACAGAGGCAGTGCAGAAGATCACCACAGAGAGCATCGTGATCTGGG^GC AAGACTCCCAAGTTCAAGCTGCCCATACAGAA GGAGACATGGGAGACATGGTGGAC CGAGTACTGGCAAGCCACCTGGATCCCTGAGTGGGAGTTCGTGAACACCCCTCCCT TGGTGAAACTGTGGTATCAGCTGGAGAAGGAACCCATCGTGGGAGCAGAGACCTTC TACGTGGATGGGGCAGCCAACAGGGAGACCAAGCTGGGCAAGGCAGGCTACGTGAC CAACCGAGGACGACAGAAAGTGGTGACCCTGACTGACACCACCAACCAGAAGACTG AGCTGCAAGCCATCTACCTAGCTCTGCAAGACAGCGGACTGGAAGTGAACATCGTG ACAGACTCACAGTACGCACTG-GGCATCATCCAAGCACAACCAGACCAATCCGAGTC AGAGCTGGTGAACCAGATCATC-GAGCAGCTGATCAAGAAGGAGAAAGTGTACCTGG CATGGGTACCAGCACACAAAGGAATTGGA'GGAAATGAACAAGTAGATAAATTAGTC AGTGCTGGGATCCGGAAGGTGCTGTTCCTGGACGGGATCGATAAGGCCCAAGATGA ACATCAGAAGTACCACTCCAACTGGCGCGCTATGGCCAGCGACTTCAACCTGCCAC CTGTAGTAGCAAAA,GAAATAGTAGCCAGCTGTGATAAATGTCAGCTAAAAGGAGAA GCCATGCATGGACAAGTAGACTGTAGTCCAGGAATATGGCAGCTGGACTGCACGCA CCTGGAGGGGAAGGTGATCCTGGTAGCAGTTCATGTAGCCAGTGGATATATAGAAG CAGAAGTTATCCCTGCTGAAACTGGGCAGGAAACAGCATATTTTCTTTTAAAATTA GCAGGAAGATGGCCAGTAAAAACAATACACACGGACAACGGAAGCAACTTCACTGG TGCTACGGTTAAGGCCGCCTGTTGGTGGGCCGGGAATCAAGCAGGAATTTGGAATTC CCTACAATCCCCAATCGCAAGGAGTCGTGGAGAGCATGAACAAGGAGCTGAAGAAG ATCATCGGACAAGTGAGGGATCAGGCTGAGCA,CCTGAAGACAGCAGTGCAGAT'GGC FIG. IC

5 U.S. Patent Oct. 27, 2009 Sheet 4 of 45 US 7,608,422 B2 AGTGTTCATCCAGAACTTCAAAAGAAAAGGGGGGATTGGG-GGGTACAGTGCAGGGG AAAGGATCGTGGACATCATCGCCAC-CGACATC-CAAACCAAG,GAGCTGCAGAAGCAG ATCACCAA GATCGAGAACTTCCGGGTGTACTACCGCGACA GCCGCAACCCACTGTG GAAGGGACCAGCAAAGCTCCTCTGGAAGGGAGAGGGGGCAGTGGTGATCCAGGACA ACA-GTGACATCAAAGTG-GTGCCAAGGCGCAAGGCCAAGATCATCCGC-GACTATGGA AAA,CAGATGGCAGGTGATGATTGTGTGGCAAGTA,GACAGGATGAGGATTAGAACCT GGAAGAGCCTGGTGAAGCACCATATG (SEQUENCE ID NO:1) FIG. ID

6 U.S. Patent Oct. 27, 2009 Sheet 5 of 45 US 7,608,422 B2 >wildtype >mutated TGTACAGAGA TGGAAAAGGA AGGGAAAATT TCAAAAATTG TGTACAGAGA TGGAGAAGGA AGGGAAGATC AGCAAGATCG # >wildtype >mutated GGCCTGAAAA TCCATACAAT ACTCCAGTAT TTGCCATAAA GGCCTGAGAA CCCCTACAAC ACTCCAGTCT TCGCAATCAA #41... >wildtype >mutated GAW.. AGAC AGTACTAAAT GGAGAAA-ATT AGTAGATTTC GAAGAAGGAC AGTACCAAGT GGA3AA0.GCT GGTGGACTTC #el... >wildtype >mutated AGAGAACTTA ATAAGAGAAC TCAAGACTTC TGGGAAGTTC AGAGAGCTGA ACAAGAGAAC TCAGGACTTC TGGGAPtGTTC # a... >wildtype >mutated AATTAGGAAT ACCACATCCC-GCAGGGTTAA AAAAGA N AGCTGGGCAT CCCACATCCC GCT.GGGTTGA AGAAGAA'GAA # >wildtype >mutated ATCAGTAACA GTACTGGATG TGGGTGATGC ATATTTT'TCA GTCAGTGACA GT'GCTGGATG TGGGTGATGC CTACTTCTCC # >wildtype >rnutated GTTCCCTTAG ATGAAGACTT CAGGAAATAT ACTGCATTTA GTTCCCTTGG ACGAGGACTT CAGGAAGTAC ACTGCCTTCA # >wildtype >mutated CCATACCTAG TATAAACAAT GAGACACCAG GGATTAGATA CGATACCTAG CATCAACAAC GAGACACCAG GCATCCGCTA # >wildtype >mutated TCAGTACAAT GTGCTTCCAC AGGGATGGAA AGGATCACCA CCAGTACAAC GTGCTGCCAC AGGGATGGAA GGGATCACCA # >wildtype >mutated GCAATATTCC AAAGTAGCAT GACAAAAATC TTAGAGCCTT GCCATCTTTC AAAGCAGCAT GAGCAAfsATC CTGGAGCCCT # r.. r r *4 * >wildtype >mutated TTAGAT~AACA AAATCCAGAC ATAGTTATCT ATCAATACAT TCCGCAAGCA AAACCCAGAC ATCGTGATCT ATCAGTACAT # FIG. 2A

7 U.S. Patent Oct. 27, 2009 Sheet 6 of 45 US 7,608,422 B2 >wildtype GGATGATTTG TATGTAGGAT CT-ACTTAGA AATAGGGCAG >mutated GGACGACCTC TACGTAGGAA GTGACCTGGA GATZGGGCAG # >wildtype CATAGAACAA AAATAGAGGA ractgagacaa CATCTGTTGA >mutated CACAGGACCA AGATCGAGGA GCTGAGACAG CATCTGTTGA # >wildtype GGTGGGGACT TACCACACCA GACAAAM.AC ATCAGAAAGA >mutated GGTGGGGACT GACCACACCA GACAAGAAGC ACCAGAAGGA # >wildtype ACCTCCATTC CTTTGGATGG GTTATGAACT CCATCCTGAT >mutated ACCTCCCTTC CTGTGGATGG GCTACGAA-CT GCATCCTGAC # >wildtype AAATGGACAG TACAGCCTAT AGTGCTGCCA GAAAAAGACA >mutated AAGTGGACAG TGCAGCCCAT CGTGCTGCCT GAGAAGGACA # >wildtype GCTGGACTGT CAAT-GACATA CAGAAGTTAG TGGGGAAATT >mutated GCTGGACTGT GAACGACATA CAGAAGCTCG TGGGCAAGTT # >wildtype GAATTGGGCA AGTCAGATTT ACCCAGGGAT TAAAGTAAGG >mutated GAACTGGGCA AGCCAGATCT ACCCAGGCAT CAAAGTTAGG # >wildtype CAATTATGTA AACTCCTTAG AGGAACCAAA GCACTAACAG >mutated CAGCTGTGCA AGCTG'CTTCCG AGGAACCAAG GCACTGACAG # >wildtype AAGTAATACC ACTAACAGAA GAAGCAGAGC TAGAACTGGC >mutated AAGTGATCCC ACTGACAGAG GAAGCAGAGC TAGAACTGGC # >wildtype AGAAAACAGA GAGATTCTAA AAGAACCAGT ACATGGAGTG >mutated AGAGAACCGA GAGATCCTGA AGGAGCCAGT ACATGGAGTG # >wildtype TATTATGACC CATCAAAAGA CTTAATAGCA GAAATACAGA >mutated TACTACGACC CAAGCAAGGA CCTGATCGCA GAGATCCAGA #

8 U.S. Patent Oct. 27, 2009 Sheet 7 of 45 US 7,608,422 B2 >wildtype >mutated AGCAGGGGCA AGGCCAATGG ACATATCAAATTTATCAAGA AGCAGGGGCA AGGCCAATGG ACCTACCAAA TCTACCAGGA # >wildtype >rmutated GC CATTTAAA AATCTGAAAA CAGGAAAATA TGCAAGAATG GOCCCTTCAAG AACCTGAAGA CAGGCAPCTA CGCAAGGATG # >wildtype AGGGGTGCCC ACACTAATGA TGTAAAACAA TTAACAGAGG >mnutated AGGGGTGCCC ACACCAACGA TGTGAAGCAG CTGACAGAGG >wildtype >mutated CAGTGCAAAA AATAACCACA GAAAGCATAG TAATATGGGG CAGTGCAGAA GATCACCACA GAGAGCATCG TGATCTGGGG # >wildtype AAAGACTCCT AAATTTAAAC TGCCCATACA AAAGGAAACA >mutated CAAGACTCCC AAGTTCAAGC TGCCCATACA GAAGGAGACA # >wildtype >mutated 4 a. r TGGGAAACAT GGTGGACAGA GTATTGGCAA GCCACCTGGA TGGGAGACAT GGTGGACCGA GTACTGGCAA GCCACCTGGA # >wildtype >mutated TTCCTGAGTG GGAGTTTGTT AATACCCCTC CTTTAGTGAA TCCCTGAGTG GGAGTTCGTG AACACCCCTC CCTTGGTGAA # r t t >wildtype >mutated ATTATGGTAC CAGTTAGAGA AAGAACCCAT AGTAGGAGCA ACTGTGGTAT CAGCTGGAGA AGGAACCCAT CGTGGGAGCA # >wildtype GAAACCTTCT ATGTAGATGG GGCAGCTAAC AGGGAGACTA >mutated GAGACCTTCT ACGTGGATGG GGCAGCCAAC AGGGAGACCA # >wildtype >mutated AATTAGGAAA GGCAGGATAT GTTACTAATA GAGGAAGACA AGCTGGGCAA GGCAGGCTAC GTGACCAACC GAGGACGACA # >wildtype >mutated AAAAGTTGTC ACCCTAACTG ACACAACAAA TCAGAAGACT GAAAGTGGTG ACCCTGACTG ACACCACCAA CCAGAAGACT # FIG. 2C

9 U.S. Patent Oct. 27, 2009 Sheet 8 of 45 US 7,608,422 B2 >wildtype GAGTTACAAG CAATTTATCT AGCTTTGCAG GATTCGGGAT >mutated GAGCTGCAAG CCATCTACCT AGCTCTGCAA GACAGCGGAC # a a a a t aaa a >wildtype TAGAAGTAAA CATAGTAACA GACTCACAAT ATGCATTAGG >mutated TGGAAGTGAA CATCGTGACA GACTCACAGT ACGCACTGGG # a. a a * a a >wildtype AATCATTCAA GCACAACCAG ATCAAAGTGA ATCAGAGTTA >mutated CA TCATCCAA GCACAACCAG ACCAATCCGA GTCAGAGCTG # <... a a aaa a a s >wiidtype GTCAATCAAA TAATAGAGCA GTTAATAAAA AAGGAAAAGG >mutated GTGAA.CCAGA TCATCGAGCA GCT-GATCAAG AAGGAGAAAG # a a a a r a a a a t >wildtype TCTATCT.GGC ATGGGTACCA GCACACAAAG GAATTGGAGG >mutated TGTACCTGGC ATGGGTACCA. GCACACAAAG GAATTGGAGG # a >wildtype AAATGAACAA GTAGATAAAT TAGTCAGTGC TGGAATCAGG >mutated AAATGAACAA GTAGATAAAT TAGTCAGTGC TGGGATCCGG a a >wildtype AAAGTACTAT TTTTAGATGG AATAGATAAG GCCCAAGATG >mutated AAGGTGCTGT TCCTGGACGG GATCGATAPG GCCCPAGATG X a... a. a a a >wildtype AACATGAGAA ATATCACAGT AATTGGAGAG CAATGGCTAG >mutated AACATGAGAA GTACCCACTCC AACTGGCGCG CTATGGCCAG # a aaa a *4 a >wildtype TGATTTTAPLC CTGCCACCTG.TAGTAGCAAA AGAAATAGTA >mutated CGACTTCAAC CTGCCACCTG TAGTAGCAAA AGAAATAGTA # a a a >wildtype GCCAGCTGTG ATAAATGTCA GCTAAAAG P. xuacatgc >mutated GCCAGCTGTG ATAAATGTCA GCTAAAAGGA GAAGCCATGC # >wildtype ATGGACAAGT AGAZTGTAGT CCAGGAATAT GGCAACTAGA >mutated ATGGACAAGT AGACTGTAGT CCAGGAATAT GGCAGCTGGh # FIG. 2D

10 U.S. Patent Oct. 27, 2009 Sheet 9 of 45 US 7,608,422 B2 >wildtype >mutated TTGTACACAT TTAGAAGGAA AAGTTATZCT GGTAGCAGTT CTGCACGCAC CTGGAGGGGA AGGTGATCCT GGTAGCAGTT # >wildtype >mutated CATGTAGCCA GTGG4TATAT AGAAGCAGAA GTTATTCCAG CATGTAGCCA GTGGATATAT AGAAGCAGAA GTTATcCCTG # >wildtype CAGAAACAGG GCAGGAAACA GCATATTTTC TTTTAAAATT >mutated CTGAAACTGG GCAGGAAACA GCATATTTTC TTTTAAAATT r >wildtype >mutated AGCAGGAAGA TGGCCAGTAA AAACAATACA TACAGACAAT AGCAGGAAGA TGGCCAGTAA AAACAATACA CACGGACAAC # >wildtype GGCAGCAATT TCA CCAGTGC TACGGTTAAG GCCGCCTGTT >mutated GGAAGCAACT TCACTGGTGC TACGGTTAAG GCCGCCTGTT a...i.... >wildtype >mutated GGTGGGCGGG AATCAAGCAG GAATTTGGAA TTCCCTACAA GGTGGGCGGG AATCAAGCAG GAATTTGGAA TTCCCTACAA # >wildtype TCCCCAAAGT CAAGGAGTAG TAGAATCTAT GAATAAAGAA >mutated TCCCCAATCG CAAGGAGTCG TGGAGAGCAT GAACAAGGAG # I >wildtype TTAAAGAAAA TTATAGGACA GGTRAGAGAT CAGGCTGAAC mutated CTGAAGAAGA TCATCGGACA AGTGAGGGAT CAGGCTGAGC # r a a + >wildtype ATCTTAAGAC AGCAGTACAA ATGGCAGTAT TCATCCACAA >mutated ACCTGAAGAC AGCAGTGCAG ATGGCAGTGT TCATCCACAA # >wildtype TTTTAAAAGA AAAGGGGGGA TTGGGGGGTA CAGTGCAGGG >mutated CTTCAAAAGA AAAGGGGGGA TTGGGGGGTA CTGCPGGG # >wildtype GAAAGAATAG TAGACATAAT AGCAACAGAC ATACAAACTA >mutated GRRAGGATCG TGGACATCAT cgccaccgac ATCCAAACCA # r a * t * t FIG. 2E

11 U.S. Patent Oct. 27, 2009 Sheet 10 of 45 US 7,608,422 B2 >wildtype >mutated AAGAATTACA AAAACAAATT ACAAAAATTC AAAATTTTCG AGGAGCTGCA GAAGCAGATC ACCAAGATCC AGAACTTCCG # >wildtype GGGTTTATTAC AGGGACA-G-CA GAAATCCACT TTGGAAAGGA >mutated GGTGTACTAC CGCGACAGCC GGCAACCCACT GTGGAAGGGA # «>wildtype CCAGCAAAGC TCCTCTGGAA AGGTGAAGGG GCAGTAGTAA >mutated CCAGCAAAGC TCCTCTGGAA GGGAGAGGGG rgcagtggtga # a >wildtype TACAAGATAA TAGTGACATA AAAGTAGTGC CAAGAAGAAA >mutated TCCAGGACAA CAGTGACATC AAAGTGGTGC CAAGGCGCAA # *44 >wildtype >mutated AGCAAAGATC ATTAGGGATT ATGGAAAACA GATGGCAGGT GGCCAAGATC ATCCG-CGACT ATGGAAAACA GATGGCAGGT # >wildtype GATGATTGTG TGGCAAGTAG ACAGGATGAG GATTAGAACA >mutated GATGATTGTG TGGCAAGTAG ACA GGATGAG GATTAGAACC # >wildtype TGGAAAAGTT TAGTAAAACA GCATATG >mutated TGGAAGAGCC TGGTGAAGCA CCATATG # FIG. 2F

12 U.S. Patent Oct. 27, 2009 Sheet 11 of 45 US 7,608,422 B2 ATGGGCGTGAGAAACTCCGTCTTGTCAGGGAAGAAAGCAGATGAATTAG AAAAAATTAGGCTACGACCCAACGGAAAGAAAAAGTACATGTTGAAGC ATGTAGTATGGGCAGCAAATGAATTAGATAGATTTGGATTAGCAGAAAG CCTGTTGGAGAACAAAGAAGGATGTCAAAAAATACTTTCGGTCTTAGCT CCATTAGTGCCAACAGGCTCAGAAAATTTAAAAAGCCTTTATAATACTG TCTGCGTCATCTGGTGCATTCACGCAGAAGAGAAAGTGAAACACACTGA GGAAGCAAAACAGATAGTGCAGAGACACCTAGTGGTGGAAACAGGAAC CACCGAAACCATGCCGAAGACCTCTCGACCAACAGCACCATCTAGCGGC AGAGGAGGAAACTACCCAGTACAGCAGATCGGTGGCAACTACGTCCAC CTGCCACTGTCCCCGAGAACCCTGAACGCTTGGGTCAAGCTGATCGAGG AGAAGAAGTTCGGAGCAGAAGTAGTGCCAGGATTCCAGGCACTGTCAG AAGGTTGCACCCCCTACGACATCAACCAGATGCTGAACTGCGTTGGAGA CCATCAGGCGGCTATGCAGATCATCCGTGACATCATCAACGAGGAGGCT GCAGATTGGGACTTGCAGCACCCACAACCAGCTCCACAACAAGGACAA CTTAGGGAGCCGTCAGGATCAGACATCGCAGGAACCACCTCCTCAGTTG ACGAACAGATCCAGTGGATGTACCGTCAGCAGAACCCGATCCCAGTAGG CAACATCTACCGTCGATGGATCCAGCTGGGTCTGCAGAAATGCGTCCGT ATGTACAACCCGACCAACATTCTAGATGTAAAACAAGGGCCAAAAGAG CCATTTCAGAGCTATGTAGACAGGTTCTACAAAAGTTTAAGAG CAGAAC AGACAGATGCAGCAGTAAAGAATTGGATGACTCAAACACTGCTGATTCA AAATGCTAACCCAGATTGCAAGCTAGTGCTGAAGGGGCTGGGTGTGAAT CCCACCCTAGAAGAAATGCTGACGGCTTGTCAAGGAGTAGGGGGGCCG GGACAGAAGGCTAGATTAATGGCAGAAGCCCTGAAAGAGGCCCTCGCA CCAGTGCCAATCCCTITTGCAGCAGCCCAACAGAGGGGACCAAGAAAGC CAATTAAGTGTTGGAATTGTGGGAAAGAGGGACACTCTGCAAGGCAATG CAGAGCCCCAAGAAGACAGGGATGCTGGAAATGTGGAAAAATGGACCA TGTTATGGCCAAATGCCCAGACAGACAGGCGGGTTTTTTAGGCCTTGGT CCATGGGGAAAGAAGCCCCGCAATTTCCCCATGGCTCAAGTGCATCAGG GGCTGATGCCAACTGCTCCCCCAGAGGACCCAGCTGTGGATCTGCTAAA GAACTACATGCAGTTGGGCAAGCAGCAGAGAGAAAAGCAGAGAGAA.AG CAGAGAGAAGCCTTACAAGGAGGTGACAGAGGATTTGCTGCACCTCAAT TCTCTCTTTGGAGGAGACCAGTAG FIG. 3

13 U.S. Patent Oct. 27, 2009 Sheet 12 of 45 US 7,608,422 B2 SIV gag #1... ATGGGGCGTGAGAAACTCCGTCTTGTCAGGGAAGAAAGCAG SIV gag #41 SIV gag #81 SIV gag #121 SIV gag #161 SIV gag #201 sly gag #241 ATGAATTAGAAAAAATTAGGCTACGACCCAACGGAAAGAA... AAAGTACATGTTGAAGCATGTAGTATGGGCAGCAAATGAA... TTAGATAGATTTGGATTAGCAGAAAGCCTGTTGGAGAACA... AAGAAGGATGTCAAAAAATACTTTCGGTCTTAGCTCCATT... AGTGCCAACAGGCTCAGAAAATTTAAAAAGCCTTTATAAT ACTGTCTGCGTCATCTGGTGCATTCACGCAGARGAGAAAG SIV gag SIVgagDX.. # TGAAACACACTGAGGAAGCAAAACAGATAGTGCAGAGACA SIVgag A--A-----T-----A--A SlVgagDX C--C-----C-----G--G # CCTAGTGGGTGGAAACAGGAACMACMGAAACYATGCCRAAR SIV gag --AAG-A sivgagdx..--ctc-c # ACMWSTMGACCAACAGCACCATCTAGCGGCAGAGGAGGAA FIG. 4A

14 U.S. Patent Oct. 27, 2009 Sheet 13 of 45 US 7,608,422 B2 SIV gag -T A--A--A T SIVgagDX..-C G--G--CC C # AYTACCCAGTACARCARATMG3GTGGTAACTAYGTCCACCT SIV gag ----T-AAG AT-A--T--C-----A--AT-- SlVgagDX..----C-GTC CC-G--C--T-----C--GC-- # GCCAYTRWSCCCGAGAACMYTRAAYGCYTGGGTMAARYTG SIV gag --A-----A SlVgagDX..--C-----G-----G--C # ATMGAGGARAAGAARTTYGGACCAGAAGTAGTCCAGGAT SIVgag -T T-----T-- SlVgagDX..-C C-----C-- # TYCAGGCACTGTCAGAAGGTTGCACCCCCTAYGACATYAA SIV gag T------T-A--T--T--G A SIVgagDX..C------C-G--C--C--T G YCAGATGYTRAAYTGYGTKGGAGACCATCARGCGGCTATG SIV gag -----T---A-A--T--T--A SIVgagDX C---C-T--C--C--C # CAGATYATCMGWGAYATYATMAACGAGGAGGCTGCAGATT SIV gag SIVgagDX..-- ft GGGACTTGCAGCACCCACAACCAGCTCCACAACAAGGACA SIV gag T--T A--T SIVgagDX C--C C--~C # ACT TAGGGAGCCGTCAGGATCAGAYATYGCACGAACMACY SIV gag AGT-----A--T-----A A-A--A- SlVgagDX..TCC-----T--C-----.G C-T--G- # WSYTCAGTWGAYGAACARATCCAGTGGATGTACMGWCARC FIG. 4B

15 U.S. Patent Oct. 27, 2009 Sheet 14 of 45 US 7,608,422 B2 SIV gag C--A T---A-GA SIVgagDX G--C C---C-TC # AGAACCCSATMCCAGTAGGCAACATYTACMGI GATGGAT SIV gag ---A-----GT----A--A--T--CA-A-----T-----A SlVgagDX..---G-----TC----G--G--C--TC-T-----C-----G # CCARCTGGGKYTGCARAARTGYGTYMGWATGTAYAACCCR SIV gag --A SlVgagDX..--C # ACMAACATTCTAGATGTAAA.CCAAGGGCCAAAAGAGCCAT SIV gag # TTCAGAGCTATGTAGACAGGTTCTACAAAAGTTTAAGAGC SIV gag # AGAACAGACAGATGCAGCAGTAAAGAATTGGATGACTCAA SIV gag # ACACT{GCTGATTCAAAATGCTAACCCPGATTGCAAGCTAG SIV gag # TGCTGAAGGGGCTGGGTGTGAATCCCACCCTAGAAGAAAT SIV gag # GCTGACGGCTTGTCAAGGAGTAGGGGGGCCGGGACAGAAG SIV gag # GCTAGATTAAT-GGCAGAAGCCCT-GAAAGAGGCCCT-CGCAC SIV gag #1121 CAGTGCCAATCGCTTTTGCAGCAGCCCAACAGAGGGGACC SIV gag # AAGAAAGCCAATTAA`GTGTTGGAATTGTGGGAAAGAGGGA FIG. 4C

16 U.S. Patent Oct. 27, 2009 Sheet 15 of 45 US 7,608,422 B2 SIV gag CACTCTGCAAGGCAATGCAGAGCCCCAAGAAGACArGGAT SIV gag * GCTGGAAATGTGGAAA ATGGACCATGTTATGGCCAAATG SIV gag CCCAGACAGACAGGGCGGGGTTTTTTAGGCCTTGGTCCATGG SIV gag # GGAAAGAAGCCCCGCAATTTCCCCAT-GGCTCAAGTGCATC SIV gag #1361 AGGiCGCI'GAI'GCCAACTGCTCCCCCAGAGGACCCP.GCTGGT SIV gag # :... GGATCTGCTAAAGAACTACATGCAGTDGGGCAAGCAGCAG SIV gag # AGAGAAAAGCAGAGAGAAAGGCAGAGAGAAGCCTTACAAGG SIV gag # AGGTGACAGAGGATTTGCTGCACiCTCAATTCTCT,CTTTGG SIV gag # AGGAGACCAGTAG FIG. 4D

17 Packaging construct CMV G g BGH poly(a) b pcmvgagpolbn Pro RT Int >y Transfer construct 1 LTR 1r1 G0 I CMV luciferase Fj LTR 1 pmbcwcnluci msd /i Q Transfer construct 2 LTR mg0 I CMV luciferose 'fi LTR pmbcwcnluci msd i/ Transfer construct 3 CMV R' 0 I CMV luciferase }1 I LTR Envelope expression CMV VS/ G poly(a) vector phcmv G intron msd MV1 LTR Gog LTR iat Pro RT lnt msd i/i FIG. 5 MV2 R RELTR

18 U.S. Patent Oct. 27, 2009 Sheet 17 of 45 US 7,608,422 B2 Soil (758) CMV promoter konamycin resistance gene pcmvgagpolbnkon (8366bp) BGH polya mgogpol Nhel (5117) BstBI (5111) FIG. 6

19 U.S. Patent Oct. 27, 2009 Sheet 18 of 45 US 7,608,422 B2 U3, PBS BssHll (711) Clal (830) Accl (959) mbc GAGmAUG Nsi 1050 CMV promoter pmbcwcnici (8937 bp) luciferose PTT U3 U5~ Clol (3259) Xhol (3548) Apo l (3557) Kpnl (3563) FIG. 7

20 U.S. Patent Oct. 27, 2009 Sheet 19 of 45 US 7,608,422 B2 BssHII (711) U3 R U5 12:11 mbc mgagmaug Nsi Clol (830) Accl (959) 1050 CMV promoter pmbcwcnici (8937 bp) luciferose PTT Clol (3259) U3 U5 Xhol (3548) Apol (3557) Kpnl (3563) FIG. 8

21 U.S. Patent Oct. 27, 2009 Sheet 20 of 45 US 7,608,422 B2 1 CCTGGCCATT GCATACGTTG TATCCATATC ATAATATGTA CATTTATATT CGCTCATCTC CAACATTACC 71 GCCATGTTGA CATTGATTAT TGACTAGTTA TTAATAGTAA TCAATTACCG GGTCATTACT TCATAGCCCA 141 TATATCCAGT TCCGCGTTAC ATAACTTACG CTAAATCGCC CGCCTGGCTG ACCGCCCAAC GACCCCCGCC 211 CATTGACGTC AATAATGACG TATGTTCCCA TAGTAACGCC AATAGGGACT TTCCATTGAC CTCAATCGGT 281 GGACTATTTA CGGTAAACTG CCCACTTGGC ACTACATCAA GTCTATCATA TGCCAACTAC CCCCCCTATT 351 GACGTCAATG ACGGTAAATG GCCCGCCTGC CATTATGCCC AGTACATGAC CTTATCGCAC TTTCCTACTT 421 GGCAGTACAT CTACGTATTA GTCATCGCTA TTACCATGGT CATGCGGTTT TGCCAGTACA TCAATGGGCG 491 TCGATAGCGG TTTGACTCAC GCGGATTTCC AAGTCTCCAC CCCATTGACG TCAATGGGAG TTTGTTTTGG 561 CACCAAAATC AACGCGACTT TCCAAAATCT CGTAACAACT CCGCCCCATT GACGCAAATG GGCGCTAGGC 631 GTCTACGGTG CGAGCTCTAT ATAAGCAGAG CTCGTTTAGT GAACCGTCAG ATCGCCTCGA CACGCCATCC Sall. (758) 70L ACCCTGTTTT GACCTCCATA GAAGACACCC GGACCCATCC AGCCTCCGCG GGCGCGCGTC CACAGAGACA 771 TGGGTGCCAG AGCGTCAGTA TTAAGCGGGG GAGAATTAGA TCGATGCCAA AAAATTCGGT TAAGGCCAGG 841 GGGAAACAAG AAGTACAAGC TAAAGCACAT CGTATGGGCA AGCAGGGAGC TAGAACGATT CCCAGTTAAT 911 CCTGGCCTGT TAGAAACATC ACAAGGCTGT AGACAAATAC TGGGACACCT ACAACCATCC CTTCAGACAG 981 CATCAGACGA GCTTCGATCA CTATACAACA CAGTAGCAAC CCTCTATTGT GTGCACCAGC CCATCGAGAT 1051 CAAGGACACC AAGGAAGCTT TAGACAAGAT AGAGGAAGAG CAAAACAAGT CCAAGAAGAA GGCCCAGCAC 1121 GCAGCAGCTG ACACAGGACA CACCAATCAG GTCAGCCAAA ATTACCCTAT AGTGCAGAAC ATCCAGGGGC 1191 AAATGGTACA TCAGGCCATA TCACCTACAA CTTTAAATGC ATGGGTAAAA GTAGTACAAG AGAAGGCTTT 1261 CAGCCCAGAA GTGATACCCA TCTTTTCAGC ATTATCAGAA GGAGCCACCC CACAGGACCT GAACACCATG 1331 TTCAACACCG TCGGGGGACA TCAAGCAGCC ATGCAAATCT TAAAAGAGAC CATCAATGAG GAACCTGCAG 1401 AATGGGATAG AGTGCATCCA CTGCATGCAG GGCCTATTGC ACCAGGCCAG ATGAGAGAAC CAAGGGGAAG 1471 TCACATAGCA GGAACTACTA.GTACCCTTCA GGAACAAATA GCATCGATGA CAAATAATCC-ACCTATCCCA 1541 GTACGAGAGA TCTACAAGAG GTGGATAATC CTCGCATTGA ACAACATCGT GAGGATGTAT AGCCCTACCA 1611 GCATTCTGGA CATAAGACAA GGACCAAAGG AACCCTTTAG AGACTATGTA CACCGGTTCT ATAAAACTCT 1681 AAGAGCTCAG CAACCTTCAC AGGAGGTAAA AAATTGGATC ACAGAAACCT TGTTGGTCCA AAATGCCAAC 1751 CCACATTCTA AGACCATCCT GAAGGCTCTC GGCCCAGCCC CTACACTAGA ACAAATGATG ACACCATCTC 1821 ACGGAGTAGG AGGACCCGGC CATAAGGCAA CACTTTTCCC CGACCCGATG AGCCAGGTGA CGAACTCCGC FIG. 9A

22 U.S. Patent Oct. 27, 2009 Sheet 21 of 45 US 7,608,422 B GACCATAATC ATCCAGACAC GCAACTTCCG CAACCAGCGC AACATCCTCA AGTGCTTCAA TTGTOGCAAA 1961 CAAGGGCACA CCCCCAGGAA CTGCCGGGCC CCCCCCAACA ACCCCTGTTG GAAATCTGGA AACCAAGCAC 2031 ACCAAATCAA AGATTCTACT GACACACAGG CTAATTTTTT ACGGAAGATC TCCCCTTCCf ACAAGGGAAG 2101 GCCACCCAAT TTTCTTCACA GCAGACCACA CCCAACACCC CCACCAGAAG ACACCTTCAG CTCTGGGGTA 2171 GAGACAACAA CTCCCCCTCA GAACCACCAG CCGATAGACA AGCAACTCTA TCCTTTAACT TCCCTCAGAT 2241 CACTCTTTCG CAACGACCCC TCCTCACACT AAGGATCGGG GGGCAACTCA AGGAACCGCT CCTCCATACA 2311 GGACCAGATC ATACAGTATT ACAAGAAATG AGTTIGCCAC GAACATCGAA ACCAAAAATC ATACGGCGGA 2381 TCGGGGCCTT CATCAACCTG ACGCACTACG ACCACATACT CATACAAATC TCTGGACATA AAGCTATAGG 2451 TACAGTATTA-CTAGCACCTA CACCTCTCAA CATAATTGCA AGAAATCTGT TGACCCAGAT CGCCTGCACC 2521 TTCAACTTCC CCATCACCCC TATTCAGACC CTCCCCCTCA AGTTGAACCC GGGGATCCAC GCCCCCAACG 2591 TCAAGCAATC CCCATTCACC AAAGAGAAGA TCAAGGCCTT AGTCGAAATC TCTACAGAGA TCGAGAAGGA 2661 AGGGAACATC ACCAAGATCC CCCCTGAGAA CCCCTACAAC ACTCCACTCT TCGCAATCAA CAACAACCAC 2731 AGTACCAACT GCAGAAAGCT GGTGCACTTC AGAGAGCTGA ACAAGAGAAC TCAGGACTrC TGGGAAGTTC 2801 AGCTGGGCAT CCCACATCCC CCTCCGTTCA ACAACAACAA CTCAGTCACA CTCCTCGATG TCGGTCATCC 2871 CTACTTCTCC GTTCCCTTGC ACCACGACTT CAGGAAGTAC ACTCCCTTCA CGATACCTAC CATCAACAAC 2941 GAGACACCAC CCATCCCCTA CCACTACAAC GTGCTGCCAC ACGCATGGAA CGGATCACCA GCCATCTTTC 3011 AAAGCACCAT CACCAAGATC CTGGAGCCCT TCCCCAAGCA AAACCCAGAC ATCCTCATCT ATCACTACAT 3081 GGACGACCTC TACCTAGGAA GTGACCTGGA GATCGGCCAC CACAGGACCA ACATCGAGGA GCTGAGACAG 3151 CATCTGTTGA GGTGGGGACT CACCACACCA GACAAGAAGC ACCACAACGA ACCTCCCTTC CTGTGCATGG 3221 GCTACCAACT CCATCCTGAC AACTGGACAG TCCACCCCAT CGTGCTGCCT GAGAACCACA GCTGGACTGT 3291 CAACGACATA CACAACCTCC TCGCCAACTT CAACTCCCCA AGCCAGATCT ACCCACGCAT CAAAGTTACC 3361 CAGCTGTGCA AGCTCCTTCG AGGAACCAAC CCACTCACAG AAGTGATCCC ACTCACACAC CAACCACAGC 3431 TACAACTGCC ACAGAACCCA CACATCCTCA ACCAGCCACT ACATCGACTG TACTACCACC CAACCAACGA 3501 CCTGATCGCA CAGATCCACA ACCAGGGGCA AGGCCAATGG ACCTACCAAA TCTACCAGGA CCCCTTCAAG 3571 AACCTGAAGA CACGCAAGTA CCCAAGGATG AGCCCTCCCC ACACCAACGA TGTGAAGCAG CTGACAGACC 3641 CAGTCCACAA CATCACCACA GAGAGCATCC TGATCTCCCG CAACACTCCC AACTTCAAGC TCCCCATACA 3711 GAAGGAGACA TCCCACACAT GGTGGACCCA GTACTGGCAA GCCACCTGGA TCCCTGAGTC CCAGTTCCTG FIG. 9B

23 U.S. Patent Oct. 27, 2009 Sheet 22 of 45 US 7,608,422 B AACACCCCTC CCTTCCTGAA ACTGTGGTAT CAGCTCCACA AGCAACCCAT CGTCCGAGCA GAGACCTTCT 3851 ACCTCCATCG GGCAGCCAAC ACGCAGACCA ACCTCCCCAA GGCAGGCTAC CTCACCAACC CAGGACGACA 3921 CAAAGTGGTC ACCCTCACTG ACACCACCAA CCAGAACACT CAGCTGCAAG CCATCTACCT AGCTCTGCAA 3991 GACAGCGGAC TGGAACTCAA CATCCTCACA CACTCACACT ACCCACTGCG CATCATCCAA CCACAACCAG 4061 ACCAATCCGA GTCACAGCTG GTCAACCACA TCATCGACCA GCTCATCAAC AAGCAGAAAG TCTACCTGGC 4131 ATCGGTACCA CCACACAAAG CAATTGGACG AAATCAACAA GTAGATAAAT TACTCAGTCC TCGCATCCCG 4201 AACCTCCTGT TCCTCGACGC CATCCATAAC CCCCAACATG AACATGACAA CTACCACTCC AACTCGCGCG 4271 CTATGGCCAC CGACTTCAAC CTGCCACCTC TAGTAGCAAA AGAAATACTA CCCAGCTCTG ATAAATGTCA 4341 CCTAAAACCA GAACCCATGC ATGGACAAGT AGACTGTAGT CCAGGAATAT CGCACCTGGA CTCCACCCAC 4411 CTGGAGGCGA AGGTCATCCT CCTAGCAGTT CATGTAGCCA CTCCATATAT AGAACCAGAA GTTATCCCTG 4481 CTCAAACTGG CCACGAAACA GCATATTTTC TTTTAAAATT ACCAGCAACA TGGCCACTAA AAACAATACA 4551 CACGGACAAC GGAAGCAACT TCACTCCTGC TACGCTTAAG GCCGCCTCTT GCTCGGCCGG AATCAAGCAG 4621 CAATTTGCAA TTCCCTACAA TCCCCAATCC CAAGCAGTCG TCGAGACCAT CAACAAGGAG CTCAAGAAGA 4691 TCATCGGACA AGTCAGGGAT CACCCTCACC ACCTCAACAC ACCAGTGCAG ATCCCACTCT TCATCCACAA 4761 CTTCAAAAGA AAACCCCCCA TTGGGGCGTA CAGTCCAGGC CAAAGGATCC TGGACATCAT CCCCACCGAC 4831 ATCCAAACCA AGGAGCTCCA CAAGCACATC ACCAACATCC AGAACTTCCG CGTGTACTAC CCCGACAGCC 4901 CCAACCCACT CTGGAACGGA CCAGCAAACC TCCTCTGGAA GCGACAGCCC CCACTCGTGA TCCACCACAA 4971 CAGTCACATC AAAGTGCTGC CAACCCGCAA GGCCAAGATC ATCCGCGACT ATCGAAAACA GATGGCACGT 5041 CATCATTGTC TCGCAACTAC ACACGATCAG CATTAGAACC TGGAAGACCC TGCTCAACCA CCATATGGCG NheI (5117) BstBI (5111) 5111 TTCCAAGCTA GCCTCGAGAT CCAGATCTGC TGTCCCTTCT AGTTGCCAGC CATCTGTTCT TTCCCCCTCC 5181 CCCGTCCCTT CCTTCACCCT GCAACGTGCC ACTCCCACTG TCCTTTCCTA ATAAAATGAG GAAATTGCAT 5251 CGCATTCTCT GACTACCTCT CATTCTATTC TGGGGGGTGG GCTGCGCCAG CACACCAACC CGGACCATTC 5321 CGAACACAAT AGCACGCATC CTCCCCATGC CCTGGGCTCT ATGCCTACCC ACCTCCTCAA GAATTGACCC 5391 CCTTCCTCCT CCCCCACAAA GAACCAGGCA CATCCCCTTC TCTCTGACAC ACCCTCTCCA CGCCCCTGGT 5461 TCTTAGTTCC AGCCCCACTC ATACCACACT CATAGCTCAG CACGCCTCCG CCTTCAATCC CACCCGCTAA 5531 AGTACTTGCA CCGCTCTCTC CCTCCCTCAT CACCCCACCA AACCAAACCT AGCCTCCAAG ACTGGGAAGA FIG. 9C

24 U.S. Patent Oct. 27, 2009 Sheet 23 of 45 US 7,608,422 B AATTAARGCA AGATAGGCTA TTAAGTGCAC ACGGACAGAA AATCCCTCCA ACATGTCAGG AAGTAATGAG 5671 AGAAATCATA GAATTTCTTC CGCTTCCTCC CTCACTGACT CGCTCCGCTC CGTCGTTCGG CTCCGGCGAC 5741 CCCTATCACC TCACTCAAAG GCGCTAATAC 5811 GTCAGCAAAA CGCCAGCAAA AGCCCAGCAA 5881 CGCCCCCCTG ACCACCATCA CAAAAATCCA 5951 GATACCAGCC GTTTCCCCCT CGAAGCTCCC 6021 CCTCTCCCCC TTrCTCCCTT CCGGAACCCT 6091 GTCTAGCTCC TTCCCTCCAA CCTCCCCTGT 6161 CCGCTAACTA TCGTCTTGAC TCCAACCCGG 6231 CAGCATTAGC AGAGCGAGGT ATCTAGCCGG 6301 ACTACAAGCA CAGTATTTCC TATCTCCCCT 6371 CTTGATCCGG CAAACAAACC ACCGCTCCTA 6441 AAAAAAAGCA TCTCAAGAAG ATCCTITCAT 6511 CGTTAAGGCA TTTTGCTCAT CAGATTATCA 6581 GTTTTAAATC AATCTAAACT ATATATGAGT 6651 ACCTATCTCA GCCATCTCTC TATTTCCTTC 6721 TCTCCCTCGT CAACAAGGTG TTGCTGACTC 6791 AGCGACCCAC GGTTCATCAC ACCTTTCTTG 6861 CGGAACCCTC TCCGTTCTCG CCAACATGCG 6931 ACAAAGCCGC CCTCCCCTCA AGTCACCGTA 7001 ACAAAAACTC ATCGACCATC AAATGAAACT 271 IPhePheGlu AspLeu4etL euhizpheg AAAAAGCCGT TTCTGTAATC AAGCAGAAAA PheLeuArgL ysclnleuse rproserphe 7141 CCGTCTGCCA TTCCCACTCC TCCAACATCA rgaspalall eg1yva1arg G1yValAspI 7211 CAACTGACAA ATCACCATCA GTCACCACTC pleuserphe AspClyHisT hrvalvalse 7281 GACTTCTTCA ACACCCCAGC CATTACGCTC 1781 Va1CInG1uV a1protrpc1 yasnargglu 7351 CGTGATTGCG CCTGACCGAC ACGAAATACG 1544 rgserglna1 aglnalaleu ArgPheValA 7421 GCAACCCGCC CAGGAACACT GCCACCCCAT sleuargarg LeuPheValA laleualaas 7491 CTCGAATGCT GTTTTCCCCG CGATCCCACT 1084 GlnPheAlaT hrlysclypr ollealathr 7561 TTCATGGTCG GAAGACCCAT AAATTCCCTC 84 4 ysllethrpr oleupromet PheGluThrL 7631 CAACGCTACC TTTGCCATGT TTCAGAAACA 61 4 avalsergly LysGlyHisL ysleuphele 7701 CGCACCTGAT TGCCCGACAT TATCGCCACC 38 4 A1aGIySerG 1nGlyValAs naspargala 7771 AATCGCCCCC TCCACCAAGA CCTTTCCCCT 14 4 euargproar gsercysser ThrGluArgG 7841 AACCAGACAG TTTTATTCTT CATCATGATA 7911 CACAACCTGG CTTTCCCCCC CCCCCCATTA 7981 ATATTTGAAT CTATTTAGAA AAATAAACAA 8051 ACGTCTAAGA AACCAITATT ATCATCACAT 8121 CGCGCGTTTC GGTGATGACG CTGAAAACCT 8191 TAACCGCATG CCCCCAGCAG ACAACCCCGT 8261 TTAACTATCC GGCATCAGAC CACATTCTAC 8331 CGTAAGGACA AAATACCGCA TCACATTCGC CCTTATCCAC ACAATCAGCG CATAACGCAC CAAAGAACAT CCGTAAAAAC GCCCCGTTGC TGGCCTTTTT CCATACCCTC CCCTCAAGTC ACAGGTGCCG AAACCCCACA GCACTATAAA TCGTCCCGCTC TCCTGTTCCC ACCCTGCCGC TTACCGGATA GGCCCTTTCT CAATGCTCAC GCTCTAGGTA TCTCACTTCG GTGCACCAAC CCCCCCTTCA GCCCCACCCC TCCCCCTTAT TAACACACCA CTTATCCCCA CTCGCACCAC CCACTGGTAA TGCTACAGAG TTCTTGAAGT GCTCGCCTAA CTACCCCTAC CTGCTCAAGC CACTTACCTT CGCAAAAAGA GTTGCTAGCT GCGGTGGTTT TTTTCTTTGC AACCAGCAGA TTACCCCCAC CTTTTCTACG GCCTCTCACG CTCACTGGAA CGAAMCTCA AAAACGATCT TCACCTAGAT CCTTTTAAAT TAAAAATGAA AAACTTGCfC TGACACTTAC CAATCCTTAA TCACTCAGCC ATCCATACTT GCCTCACTCC GGCCGCCGGG GCCGCTCACG ATACCACGCC TGAATCGCCC CATCATCCAG CCAGAAACTG TACGTCGACC AGTTCGTGAT TTTCAACT2T TGCTTTGCCA TGATCTGATC CTTCAACTCA GCAAAAGTTC CATTTATTCA ATCCTCTGCC AGTGTTACAA CCAATTAACC AATTCTCATT CCAATTTATT CATATCAGCA TTATCAATAC CT-j,TTTG nleulysasn MetAspProA snasplieci ytyrlyscln CTCACCGACC CAGTTCCATA GGATCCCAAC ATCCTGGTAT G1uGlyLeuC ysasntrple ullealaleu AspGlnTyrA ATACAACCTA TTAATTTCCC CTCGTCAAAA ATAAGGTTAT lecyaclyll eleulyacly C1uAspPheI leleuasnas AATCCCCTCA CAATGGCAAA ACCTTATCCA TTTCTTTCCA raspproser PheProLeuL eulyshisme tglulystrp CTCATCAAAA TCACTCCCAT CAACCAAACC GTTATTCATT AspAspPheA spseralaas pvaileugly AsnAsnMetA CCATCGCTCT TAAAAGGACA ATTACAAACA GGAATCCAAT rgaspseras npheprocys AsnCysValP roileserki CAACAATATT TTCACCTGAA TCAGGATATT CTTCTAATAC pvallleasn GluGlySerA spprotyrgi ugluleuva1 GCTCACTAAC CATCCATCAT CACGAGTACG CATAAAATGC ThrLeuLeuT rpalaaspas pprothrarg IlePheHisL ACCCACTTTA GTCTGACCAT CTCATCTG.TA ACATCATTGG eutrpasnle uargvalmet G1uAspThrV alaspasnal ACTCTGGCGC ATCGGGCTTC CCATACAATC_G(,TACATTGT ucluproala AspProLysC lytyrleuar gtyrllethr CCATTTATAC CCATATAAAT CAGCATCCAT CTTCGAAYTT TrpLysTyrC lytyrleuas palaaspmet AsnSerAsnL TGAATATGGC TCATAACACC CCTTGTATTA CTCTTTATCT 1nIleRisSe rmet TATTTTTATC TTGTGCAATG TAACATCAGA GATTTTGAGA TTGAAGCATT TATCACGGTT ATTGTCTCAT GAGCGGATAC ATAGCGGTTC CGCGCACATT TCCCCCAAAA GTGCCACCTC TAACCTATAA AAATAGGCCT ATCACGAGGC CCITTCCTCT CTGACACATG CACCTCCCGG AGACGGTCAC ACCTTGTCTC CAGGCCCCGT CACCGGGTGT TGGCGCCTCT CCGCGCTGGC CTAGACTGCA CCATATGCGG TCTGAAATAC CCCACAGATC TATTGG (SEQUENCE ID NO: 6) FIG. 9D

25 U.S. Patent Oct. 27, 2009 Sheet 24 of 45 US 7,608,422 B2 1 TGCAAGGCCT AATTTCGTCC CAAAAAACAC AACACATCCT TCATCTGTGG ATCTACCACA CACAAGGCTA 71 CTTCCCTCAT TGGCACAACT ACACACCACG GCCACCGATC ACATATCCAC TCACCTTTGG ATCCTGCTTC 141 AACTTACTAC CACTTGAACC ACACCAACTA CAACAGCCCA AATAAGCAGA GAAGAACACC TTGTTACACC 211 CTATGAGCCA CCATGCCATC CAGGACCCCG ACGCACAACT ATTACTCTCG AACTTTCACA GCCTCCTACC 281 ATTTCGTCAC ATGGCCCCAC ACCTGCATCC GCACTACTAC AAACACTGCT CACATCCAGC TTTCTACAAC 351 CCACTTTCCC CTGCCGACTT TCCAGGGAGG TGTGGCCTCG GCGGCACTGG GGACTCGCCA GCCCTCACAT 421 CCTACATATA AGCAGCTGCT TTTTCCCTCT ACTGCCTCTC TCTGGTTACA CCAGATCTCA CCCTGGGACC 491 TCTCTGGCTA ACTACCCAAC CCACTGCTTA AGCCTCAATA AAGCTTGCCT TGAGTGCTCA AACTACTCTG 561 TCCCCCTCTG TTCTGTGACT CTGGTAACTA CACATCCCTC AGACCCTTTT AGTCAGTCTG GAAAATCTCT 631 ACCACTCCCC CCCCAACAGG GACTTGAAAG CGAAAGTAAA GCCAGAGGAG ATCTCTCGAC GCAGGACTCG BssHII (711) 701 CCTTGCTGAA GCGCCCacgg caagaggcga ggggcggcgc ctgacgagga cgccaaaaat tttgactagc C1aI (830) 771 ggaggctaga aggagagagc TCGCTCCCAG ACCGTCAGTA TCAAGCGGGG CAGAATTACA TCCATGGCAA 841 AAAATTCGCT TAAGCCCAGG GGGAAAGAAA AAATATAAAT TAAAACATAT AGTATGGGCA ACCAGGGAGC AccI (959) 911 TAGAACGATT CGCACTTAAT CCTGGCCTCT TACAAACATC AGAAGGCTGT ACACAAATAC TGGGACAGCT 981 ACAACCATCC CTTCAGACAC CATCAGAACA ACTTAGATCA TTATATAATA CACTAGCAAC CCTCTATTGT 1051 CTCCATCAAA CCATACAGAT AAAAGACACC AACGAAGCTT TACACAAGAT AGAGGAAGAG CAAAACAAAA FIG. 10A

26 U.S. Patent Oct. 27, 2009 Sheet 25 of 45 US 7,608,422 B GTAAGAAAAA AGCACACCAA GCAGCACCTG ACACAGGACA CACCAATCAG GTCAGCCAAA ATTACCCTAT 1191 AGTGCAGAAC ATCCAGGCGC AAATGGTACA TCAGGCCATA TCACCTAGAA CTTTAAACGA TP.AGCTTGGG 1261 AGTTCCGCGT TACATAACTT ACGGTAAATG GCCCGCCTGC CTCACCGCCC AACGACCCCC GCCCATTGAC 1331 GTCAATAATG ACGTATCTTC CCATACTAAC GCCAATAGGG ACTTTCCATT GACGTCAATG GGTGGAGTAT 1401 TTACGGTAAA CTGCCCACTT GGCAGTACAT CAACTCTATC ATATGCCAAG TACGCCCCCT ATTGACGTCA 1471 ATGACGGTAA ATCCCCCGCC TGGCATTATG CCCAGTACAT GACCTTATCG GACTTTCCTA CTTGGCAGTA 1541 CATCTACGTA TTAGTCATCG CTATIACCAT GGTGATCCGG TTITGGCAGT ACATCAATGG GCGTCGATAG 1611 CGGTTTGACT CACGGGGATT TCCAAGTCTC CACCCCATTG ACGTCAATGG GAGTTTGTIT TGGCACCAAA 1681 ATCAACGGGA CTTTCCAAAA TGTCGTAACA ACTCCGCCCC ATTGACGCAA ATGGGCGGTA GGCGTGTACG 1751 GTGGGAGGTC TATATAAGCA CAGCTCCTTT AGTGAACCGT CAGATCGCCT GGAGACCCCA TCCACGCTCT 1821 TTTGACCTCC ATACAACACA CCGACTCTAG AGgatccATC TAAGTAAGCT TGGCATTCCG GTACTGTTGG 1891 TAAAATGGAA CACGCCAAAA ACATAAAGAA AGGCCCGGCG CCATTCTATC CTCTAGAGCA TGGAACCGCT 1961 GGAGAGCAAC TGCATAAGGC TATGAAGAGA TACGCCCTGC TTCCTGGAAC AATTGCTTTT ACACATCCAC 2031 ATATCGAGGT GAACATCACG TACGCGGAAT ACTTCGAAAT GTCCGTTCGG TTGGCAGAAG CTATGAAACG 2101 ATATGGGCTG AATACAAATC ACAGAATCGT CCTATGCAGT GAAAACTCTC TTCAATTCTT TATGCCGCTG 2171 TTGGGCCCGT TATTTATCCG AGTTGCAGTT GCGCCCGCCA ACGACA:TIA TAATGAACGT GAATTGCTCA 2241 ACAGTATCAA CATTTCGCAG CCTACCGTAG TCTTTGTTTC CAAAAAGGGG TTCCAAAAAA TTTTGAACGT 2311 GCAAAAAAAA TTACCAATAA TCCACAAAAT TATTATCATG CATTCTAAAA CGGATTACCA GGGATTTCAG FIG. 10B

27 U.S. Patent Oct. 27, 2009 Sheet 26 of 45 US 7,608,422 B TCGATCTACA CGTTCGTCAC ATCTCATCTA CCTCCCGCTT TTAATGAATA CGATTTTCTA CCACACTCCT 2451 TTCATCGTGA CAAAACAATT GCACTGATAA TCAATTCCTC TCCATCTACT GGGTTACCTA AGGGTCTCGC 2521 CCTTCCGCAT AGAACTCCCT GCGTCAGATT CTCCCATGCC ACAGATCCTA TTTTTGGCAA TCAAATCATT 2591 CCCGATACTC CCATITTAAG TGTTGTTCCA TTCCATCACG CTTTTGGAAT GTTTACTACA CTCGGATATT 2661 TCATATGTGG ATTTCGAGTC GTCTTAATCT ATAGATTTGA ACAAGAGCTG TTTTTACGAT CCCTTCAGCA 2731 TTACAAAATT CAAACTCCGT TGCTAGTACC AACCCTATTT TCATTCTTCG CCAAAAGCAC TCTGATTGAC 2801 AAATACGATT TATCTAATTT ACACGAAATT GCTTCTGGGG GCGCACCTCT TTCGAAAGAA CTCCGGGAAG 2871 CGGTTGCAAA ACCCTTCCAT CTTCCAGGCA TACGACAACG ATATCGCCTC ACTCAGACTA CATCAGCTAT 2941 TCTGATTACA CCCGAGGGGG ATGATAAACC CGCCCCCGTC GGTAAAGTTG TTCCATTTTT TGAAGCCAAG 3011 GTTGTGGATC TGGATACCGG GAAAACCCTG GGCGTTAATC AGAGAGGCGA ATTATGTGTC AGAGGACCTA 3081 TGATTATGTC CCGTTATGTA AACAATCCGG AAGCCACCAA CCCCTTGATT GACAAGGATC GATCGCTACA 3151 TTCTGGACAC ATAGCTTACT GGGACGAAGA CGAACACTTC TTCATAGTTG ACCGCTTGAA GTCTTTAATT Clal (3259) 3221 AAATACAAAG CATATCAGGT GGCCCCCCCT GAATTGGAAT CGATATTCTT ACAACACCCC AACATCTTCG 3291 ACCCGGGCGT GGCAGGTCTT CCCGACGATC ACGCCCGTGA ACTTCCCGCC GCCGTTCTTG TTTTGGAGCA 3361 CGGAAAGACG ATGACGGAAA AAGAGATCGT GGATTACGTC GCCAGTCAAG TAACAACCCC GAAAAACTTG 3431 CGCCGAGGAG TTGTCTTTGT GGACGAAGTA CCGAAAGGTC TTACCGGAAA ACTCCACGCA AGAAAAATCA Apal (3557) Xhol (3548) Kpnl(3563) 3501 CACACATCCT CATAAAGGCC AAGAAGGGCG GAAAGTCCAA ATTGTAAcTC GAGGGGCGCC CCGCTACCTT FIG. 10C

28 U.S. Patent Oct. 27, 2009 Sheet 27 of 45 US 7,608,422 B TAAGACCAAT GACTTACAAG GCAGCTGTAG ATCTTAGCCA CTTTTTAAAA GAAAACGGGG CACTGGAAGG 3641 CCTAATTCAC TCCCAAAGAA GACAACATAT CCTTCATCTG TCGATCTACC ACACACAACC CTACTTCCCT 3711 CATTCGCACA ACTACACACC AGGGCCAGGG GTCAGATATC CACTGACCTT TGGATGGTGC TACAAGCTAG 3781 TACCAGTTCA CCCACATAAG GTAGAAGAGG CCAATAAAGG ACACAACACC ACCTTCTTAC ACCCTCTCAC 3851 CCTGCATGGA ATGGATGACC CTCAGAGAGA ACTCTTAGAG TGGAGGTTTG ACAGCCGCCT AGCATTTCAT 3921 CACGTGGCCC CAGAGCTGCA TCCGGAGTAC TTCAAGAACT GCTGACATCG AGCTTGCTAC AAGGGACTTT 3991 CCGCTGGGGA CTTTCCAGGG AGGCGTGGCC TGGCCGGGAC TGGGGAGTGG CGAGCCCTCA GATGCTGCAT 4061 ATAAGCAGCT GCTTTTTGCC TGTACTCGGT CTCTCTGGTT AGACCAGATC TGAGCCTGGG ACCTCTCTGG 4131 CTAACTAGGG AACCCACTGC TTAAGCCTCA ATAAAGCTTG CCTTGAGTGC TTCAACTAGf GTGTCCCCGT 4201 CTGTTGTGTC ACTCTCGTAA CfAGAGATCC CTCAGACCCT TTTAGTCACT GTCGAAAATC TCTAGCACCC 4271 CCCAGGAGGT AGAGGTTGCA GTGAGCCAAG ATCCCGCCAC TGCATTCCAG CCTGGGCAAG AAAACAAGAC 4341 TGTCTAAAAT AATAATAATA AGTTAAGGGT ATTAAATATA TTTATACATG GACCTCATAA AAATATATAT 4411 ATTTGCGCTG CGCGCAGTGC CTCACACCTG CCCCCGGCCC TTTGGGAGGC CGAGCCACCT GGATCACCTG 4481 AGTTTGCGAG TTCCACACCA CCCTGACCAA CATGGAGAAA CCCCTTCTCT CTGTATTTTT ATGAGATTTT 4551 ATTTTATCTG TATTTTATTC ACAGGTATTT CTGGAAAACT GAAACTGTTT TTCCTCTACT CTGATACCAC 4621 AAGAATCATC ACCACAGAGG AAGACTTCTG TGATCAAATG TGGTGGGAGA GGGAGCTTTT CACCAGCACA 4691 TGACCAGTCA GTTCTGCCGC ACACTCGGCC CCTCTCCTTC CGTTCAGTTC CAACACCGCC TGCCTGCAGA 4761 GAGGTCAGAC CACAGCGTGA GGGCTCAGTC CCCAACACAT AAACACCCAA CACATAAACA CCCAACAGGT 4831 CCACCCCGCC TGCTGCCCAG GCAGAGCCGA TTCACCAAGA CGGGAATTAG GATAGAGAAA GAGTAAGTCA 4901 CACACACCCG GCTGTCCCGG AGAACGGAGT TCTATTATGA CTCAAATCAC TCTCCCCAAC CATTCGGGGA 4971 TCAGAGTTTT TAACGATAAC TTACTGTGTA GGGCGCCAGT GACTTGGAGA TGAAAGCGTA GGGAGTCGAA 5041 GGTGTCCTTT TGCGCCGAGT CAGTTCCTGG GTGGGGGCCA CAAGATCGGA TGACCCACTT TATCAATCCG 5111 GGGGTGCCAG CTCATCCATG GAGTGCACGG TCTCCAAAAT ATCTCAAGCA CTGATTGATC TTAGGTT'[TA 5181 CAATAGTGAT GTTACCCCAG GAACAATTTG GGGAAGGTCA GAATCTTGTA GCCTGTAGCT GCATGACTCC 5251 TAAACCATAA TTTCITTITT GTTTT TTCIT TTTTATTTTT GAGACAGGGT CTCACTCTCT CACCTAGCCT 5321 GGAGTGCAGT GCTGCAATCA CAGCTCACTC CAGCCCCTAG AGCGGCCGCC ACCGCCCTCG ACCTCCAATT 5391 CGCCCTATAC TCACTCGTAT TACAATTCAC TGGCCGTCCT TTTACAACGT CCTGACTGGG AAAACCCTGC 5461 CGTTACCCAA CTTAATCGCC TTGCAGCACA TCCCCCTTTC GCCAGCTGGC GTAATAGCGA AGAGCCCCCC 5531 ACCCATCGCC CTTCCCAACA CTTGCCCACC CTGAATGGCG AATGGCGCGA AATTCTAAAC CTTAATATTT 5601 TGITAAAATT CGCGTTAAAT TTTTGTTAAA TCAGCTCATT TTTTAACCAA TAGGCCGAAA TCGGCAAAAT 5671 CCCTTATAAA TCAAAAGAAT AGACCGACAT ACCCTTGAGT GTTCTTCCAC TTTCGAACAA GAGTCCACTA 5741 TTAAAGAACG TGGACTCCAA CGTCAAAGGG CGAAAAACCG TCTATCAGGG CGATGGCCCA CTACGTGAAC 5811 CATCACCCTA ATCAAGTTTT TTGGGGTCGA GGTGCCCTAA AGCACTAAAT CCCAACCCTA AAGCGAGCCC 5881 CCGATTTAGA GCTTGACGGC GAAAGCCGGC GAACGTGGCC ACAAAGGAAG GGAACAAAGC CAAAGGACCG FIG. 10D

29 U.S. Patent Oct. 27, 2009 Sheet 28 of 45 US 7,608,422 B GGCGCTACGG CCCTCGCAAG TCTAGCGGTC ACGCTGCGCG TAACCACCAC ACCCGCCCCG CTTAATGCGC 6021 CGCTACAGGG CGCGTCCCAG GTGGCACTTT TCCGGCAAAT CTCCGCGGAA CCCCTATTTG TTTATTTTTC 6091 TAAATACATT CAAATATGTA TCCGCTCATG ACACAATAAC CCTGATAAAT GCTTCAATAA TATTGAAAAA 6161 GGAAGAGTAT GAGTATTCAA CATTTCCGTG TCGCCCTTAT TCCCTTTTTT CCGGCATTTT GCCTTCCTCT 6231 TTTTGCTCAC CCAGAAACGC TGCTGAAAGT AAAAGATGCT GAAGATCAGT TGGGTGCACG AGTGGGTTAC 6301 ATCCAACTGG ATCTCAACAC CGCTAAGATC CTTCACACTT TTCGCCCCGA AGAACGTTTT CCAATGATGA 6371 GCACTTITAA AGTTCTCCTA TGTGGCGCGG TATTATCCCG TATTGACCCC GGGCAACAGC AACTCCGTCG 6441 CCGCATACAC TATTCTCAGA ATCACTTCCT TGACTACTCA CCAGTCACAC AAAAGCATCT TACCGATGGC 6511 ATGACACTAA GAGAATTATG CAGTGCTGCC ATAACCATGA GTGATAACAC TGCGCCCAAC TTACTTCTGA 6581 CAACGATCGG ACGACCCAAG GAGCTAACCC CTTTTTTGCA CAACATGGGG GATCATCTAA CTCGCCTTGA 6651 TCCTTGGGAA CCGGAGCTGA ATCAACCCAT ACCAAACGAC CACCGTCACA CCACGATCCC TGTAGCAATG 6721 CCAACAACCT TGCCCAAACT ATTAACTGGC CAACTACTTA CTCTACCTTC CCGGCAACAA TTAATACACT 6791 GGATGGAGGC CGATAAAGTT GCAGGACCAC TTCTCCGCTC CGCCCTTCCC CCTGGCTGGT TTATTCCTGA 6861 TAAATCTGGA CCCGGTGACC GTGGCTCTCG CGGTATCATT GCACCACTGG CGCCAGATGG TAACCCCTCC 6931 CGTATCGTAG TTATCTACAC CACGGCCAGT CAGGCAACTA TGCATCAACG AAATAGACAG ATCGCTGAGA 7001 TAGGTGCCTC ACTGATTAAG CATTGGTAAC TGTCAGACCA AGTTTACTCA TATATACTTT AGATTGATTT 7071 AAAACTTCAT TTTTAATTTA AAAGGATCTA GGTCAAGATC CTTTTLGATA ACTTCATCAC CAAAATCCCT 7141 TAACGTGACT TTTCCTTCCA CTGACCGTCA CACCCCGTAG AAAAGATCAA AGGATCTTCT TGAGATCCTT 7211 TTTTTCTGCG CGTAATCTGC TGCTTCCAAA CAAAAAAACC ACCGCTACCA GCCGTGGTTT GTTTCCCGGA 7281 TCAAGAGCTA CCAACTCTTT TTCCGAAGGT AACTGGCTTC AGCAGACCGC AGATACCAAA TACTGTCCTT 7351 CTAGTGTAGC CGTAGTTAGC CCACCACTTC AAGAACTCTG TACCACCGCC TACATACCTC GCTCTGCTAA 7421 TCCTGTTACC AGTGGCTGCT GCCAGTGCCC ATAACTCGTG TCTTACCGGG TTGGACTCAA GACGATAGTT 7491 ACCGGATAAG CCCCAGCGGT CGGGCTGAAC GGGGGGTTCG TCCACACAGC CCAGCTTGGA GCGAACGACC 7561 TACACCGAAC TGAGATACCT ACAGCGTCAG CTATGACAAA GCGCCACGCT TCCCGAAGGG AGAAAGGCGG 7631 ACAGGTATCC CGTAAGCGCC AGGGTCGGAA CAGGACACCG CACGAGGCAG CTTCCAGGGC GAAACGCCTG 7701 GTATCTTTAT ACTCCTGTCG.GcTTTCGCCA CCTCTCACTT GAGCGTCGAT '1'TTTCTGATG CTCCTCAGGG 7771 GGGCGGAGCC TATGGAAAAA CGCCACCAAC GCGGCCTTTT TACGGTTCCT GGCCTTTTGC TGGCCTTTTG 7841 CTCACATGTT CTTTCCTGCG TTATCCCCTG ATTCTCTGGA TAACCCTATT ACCGCCTTTG ACTGAGCTGA 7911 TACCGCTCGC CGCAGCCCAA CGACCGAGCC CAGCGACTCA CTGAGCCAGG AAGCCCAAGA GCGCCCAATA 7981 CGCAAACCGC CTCTCCCCGC GCGTTCCCCG ATTCATTAAT GCAGCTCGCA CGACAGCTTT CCCGACTGGA 8051 AAGCGGCCAG TGAGCCCAAC GCAATTAATC TGAGTTAGCT CACTCATTAG GCACCCCAGG CTITACACTT 8121 TATGCTTCCG GCTCCTATGT TGTGTCCAAT TCTGACCGGA TAACAATTTC ACACACCAAA CAGCTATGAC 8191 CATGATTACC CCAACCTCCG AATTAACCCT CACTAAAGCG AACAAAAGCT GCTGCAGGCT CCCTAACTGC 8261 CAACCCCCAC ACTGTCCCCT CAGGCTGCCC CTTCCTTCTA GCGCCTGCCC CCACTCCGCT TTCCTCTCCC 8331 TACTTTCACT TACTTCCGTT CAGCCAAGGT CTGAAACTAG GTGCGCACAG AGCGCTAAGA CTCCGAGAGA 8401 AAGAGACCAG CTTTACACGG GGTTTATCAC ACTGCACCCT GACAGTCGTC ACCCTCACAG CGGGTTTATC 8471 ACATTCCACC CTGACACTCG TCACCCTCAC AGGGGGTTTA TCACAGTGCA CCCTTACAAT CATTCCATTT 8541 GATTCACAAT YTTTTTAGTC TCTACTCTGC CIAACTTGTA ACTTAAATTT CATCAGAGGT GTGTTCGCAC 8611 AGGCGAAAAC ACTATATACA GGGTTCACTA CTATCGCATT TCACGCCTCC ACCTGGCTCT TGGAATGTGT 8661 CCCCCGAGGG CTGATGACTA CCTCAGTTCG ATCTCCACAG CTCACACTGA CACAACATAA CCAAGACACC 8751 TCCCAAGGCT ACCACAATGG GCCCCCCTCC ACGTGCACAT GCCCGGAGGA ACTGCCATGT CGGAGGTGCA 8821 AGCACACCTC CGCATCAGAG TCCTTGGTGT GGACGGAGGG ACCACCCCAC CTTCCAGCCA TCCACCTCAT 8891 GAACAGAACC TACCGAAACC CCCAGTTCTA CTTACACCAG GAAAGGC (SEQUENCE ID NO: 8) FIG. 1 of

30 U.S. Patent Oct. 27, 2009 Sheet 29 of 45 US 7,608,422 B2 1 TGGAAGGGCT AATTTGGTCC CAAAAAAGAC AAGAGATCCT TGATCTGTCG ATCTACCACA CACAAGGCTA 71 CTTCCCTCAT TGGCAGAACT ACACACCAGG GCCAGGGATC ACATATCCAC TGACCTTTGG ATGGTGCTTC 141 AAGTTACTAC CAGTTGAACC AGAGCAACTA CAAGAGGCCA AATAAGGACA CAAGAACAGC TTGTTACACC 211 CTATGACCCA GCATGGGATG GAGCACCCGG AGGGAGAAGT ATTAGTGTGG AAGTTTCACA GCCTCCTAGC 281 ATTTCGTCAC ATGGCCCGAG AGCTCCATCC GGACTACTAC AAACACTCCT GACATCGAGC TTTCTACAAG 351 GGACTTTCCG CTGGGGACTT TCCAGGGAGG TCTGGCCTGG GCGGGACTGC GCAGTGGCGA GCCCTCACAT 421 GCTACATATA AGCAGCTGCT TTTTGCCTCT ACTGGGTCTC TCTGCTTAGA CCAGATCTGA GCCTGGCACC 491 TCTCTGCCTA ACTAGGGAAC CCACTGCTTA AGCCTCAATA AACCTTGCCT TGAGTGCTCA AAGTACTGTG 561 TGCCCGTCTG TTGTCTGACT CTGGTAACTA GAGATCCCTC AGACCCTTTT AGTCAGTGTG GAAAATCTCT 631 AGCAGTGGCG CCCGAACAGG GACTTGAAAC CCAAACTAAA GCCAGAGGAG ATCTCTCGAC GCAGGACTCG BssHII (711) 701 GCTTGCTGAA CCGCGCacgg caagaggcga ggggcggcgc ctgacgagga cgccaaaaat tttgactagc ClaI (830) 771 ggaggctaga aggagagagc TCGGTGCGAG AGCGTCAGTA TTAAGCCGGC GAGAATTAGA TCCATGCCAA 841 AAAATTCGGT TAAGGCCAGG GGGAAAGAAG AAGTACAAGC TAAACCACAT CGTATGGCCA AGCAGGGAGC Accl (959) 911 TAGAACGATT CGCAGTTAAT CCTGGCCTGT TAGAAACATC AGAAGCCTCT AGACAAATAC TGGGACAGCT 981 ACAACCATCC CTTCAGACAG GATCAGAGGA GCTTCGATCA CTATACAACA CACTAGCAAC CCTCTATTGT 1051 GTGCACCAGC CGATCGACAT CAAGGACACC AACGAACCTT TAGACAAGAT ACAGCAAGAC CAAAACAACT 1121 CCAAGAAGAA GGCCCAGCAG CCACCAGCTG ACACAGGACA CACCAATCAG CTCAGCCAAA ATTACCCTAT FIG. 11 A

31 U.S. Patent Oct. 27, 2009 Sheet 30 of 45 US 7,608,422 B AGTGCAGAAC ATCCAGGGGC AAATGGTACA TCACGCCATA TCAGCTAGAA CTTTAAACGA TAAGCTTGGG 1261 AGTTCCGCGT TACATAACTT ACGGTAAATG GCCCGCCTGG CTGACCGCCC AACGACCCCC GCCCATTGAC 1331 GTCAATAATG ACGTATGTTC CCATAGTAAC GCCAATAGGG ACTTTCCATT GACGTCAATG GGTGCACTAT L401 TTACCGTAAA CTGCCCACST GGCA!GTACAT CAAGTGTATC ATATGCCAAG TACCCCCCCT ATTCACCTCA 1471 ATGACGCTAA ATGGCCCCCC TGGCATTATG CCCAGTACAT GACCTTATCC CACTTTCCTA CTTGGCAGTA 1541 CATCTACGTA TTAGTCATCG CTATTACCAT GGTGATGCGG TTTTGGCAGT ACATCAATGG GCGTGGATAG 1611 CCGTTTGACT CACGGGGATT TCCAAGTCTC CACCCCATTG ACGTCAATGG GAGTTTGTTT TGGCACCAAA 1681 ATCAACGGGA CTTTCCAAAA TGTCCTAACA ACTCCCCCCC ATTGACCCAA ATGGGCCGTA GGCGTGTACG 1751 GTGGGAGGTC TATATAACCA GAGCTCGTTT AGTGAACCGT CAGATCCCCT GGAGACGCCA TCCACGCTCT 1821 TTTGACCTCC ATAGAAGACA CCGACTCTAG AGgatccATC TAAGTAAGCT TGGCATTCCG GTACTGTTGG 1891 TAAAATGCAA GACGCCAAAA ACATAAAGAA AGCCCCGGCG CCATTCTATC CTCTAGAGGA TGGAACCGCT 1961 GGAGAGCAAC TGCATAAGGC TATCAACAGA TACCCCCTGG TTCCTGGAAC AATTGCTTTT ACACATGCAC 2031 ATATCGAGCT GAACATCACG TACGCGGAAT ACTTCGAAAT CTCCCTTCGG TTGGCAGAAC CTATGAAACG 2101 ATATGGGCTG AATACAAATC ACACAATCGT CGTATGCAGT GAAAACTCTC TTCAATTCTT TATGCCGCTC 2171 TTGGGCCCGT TATTTATCCG AGTTGCAGTT GCGCCCGCGA ACGACATTTA TAATGAACGT CAATTGCTCA 2241 ACAGTATGAA CATTTCGCAG CCTACCGTAG TCTTtGTITC CAAAAAGGGG TTGCAAAAAA TTTTGAACGT 2311 GCAAAAAAAA TTACCAATAA TCCACAAAAT TATTATCATG CATTCTAAAA CCGATTACCA GCGATTTCAG 2381 TCGATGTACA CGTTCGTCAC ATCTCATCTA CCTCCCGGTT TTAATCAATA CGATTTTCTA CCAGACTCCT FIG. 11B

32 U.S. Patent Oct. 27, 2009 Sheet 31 of 45 US 7,608,422 B TTGATCGTGA CAAAACAATT CCACTCATAA TGAATTCCTC TGGATCTACT GGGTTACCTA AGCGTCTGGC 2521 CCTTCCGCAT AGAACTCCCT GCGTCACATT CTCGCATGCC ACAGATCCTA TTTTTGGCAA TCAAATCATT 2591 CCGGATACTG CGATTTTAAG TGTTGTTCCA TTCCATCACG GTTTTGGAAT CTTTACTACA CTCGCATATT 2661 TGATATGTGG ATTTCGAGTC GTCTTAATGT ATAGATTTGA AGAAGAGCTG TTTTTACCAT CCCTTCACCA 2731 TTACAAAATT CAAAGTGCGT TGCTAGTACC AACCCTATTT TCATTCTTCG CCAAAAGCAC TCTCATTGAC 2801 AAATACGATT TATCTAATTT ACACGAAATT GCTTCTGGGG GCGCACCTCT TTCGAAAGAA CTCGCGGAAG 2871 CGCTTGCAAA ACGCTTCCAT CTTCCAGGCA TACGACAAGC ATATGGGCTC ACTGAGACTA CATCAGCTAT' 2941 TCTGATTACA CCCGAGCGGG ATGATAAACC GGGCGCGGTC GGTAAAGTTG TTCCATTTTT TGAAGCGAAG 3011 GTTCTGCATC TGGATACCGG GAAAACGCTG GCCGTTAATC AGAGAGCCCA ATTATGTGTC AGAGGACCTA 3081 TGATTATGTC CCGTTATGTA AACAATCCCC AACCGACCAA CGCCTTGATT CACAACCATG GATGGCTACA 3151 TTCTGGAGAC ATAGCTTACT GGGACGAACA CGAACACTTC TTCATAGTTG ACCGCTTCAA CTCTTTAATT Clal (3259) 3221 AAATACAAAG CATATCAGGT CGCCCCCGCT CAATTGGAAT CGATATTCTT ACAACACCCC AACATCTTCG 3291 ACGCCGGCGT GGCAGCTCTT CCCGACGATG ACGCCGCTCA ACTTCCCCCC GCCGTTGTTG TTTTGCAGCA 3361 CGGAAAGACG ATGACGGAAA AAGAGATCGT CGATTACCTC CCCAGTCAAC TAACAACCCC GAAAAAGTTG 3431 CGCCGAGGAC TTGTCTTTGT GGACGAAGTA CCGAAAGGTC TTACCGGAAA ACTCGACCCA ACAAAAATCA Apal (3557) Xhol (3548) Kpnl(3563) 3501 GAGAGATCCT CATAAAGCCC AAGAACCGCC GAAAGTCCAA ATTGTAAcTC GAGGCCCGGC CCGGTACCTT 3571 TAACACCAAT CACTTACAAG CCAGCTGTAG ATCTTAGCCA CTTTTTAAAA GAAAAGGGGG CACTGGAAGG FIG. 110

33 U.S. Patent Oct. 27, 2009 Sheet 32 of 45 US 7,608,422 B GCTAATTCAC TCCCAAAGAA GACAACATAT CCTTCATCTG TGGATCTACC ACACACAAGG CTACTTCCCT 3711 GATTGGCAGA ACTACACACC ACGCCCAGCG GTCAGATATC CACTCACCTT TCGATGGTCC TACAAGCTAG 3781 TACCAGTTGA GCCAGATAAC CTAGAAGAGG CCAATAAAGG AGAGAACACC AGCTTGTTAC ACCCTGTGAG 3851 CCTGCATGGA ATGGATGACC CTGAGACAGA AGTGTTACAC TGGAGGTTTG ACAGCCGCCT AGCATTTCAT 3921 CACGTGGCCC GAGAGCTGCA TCCGCAGTAC TTCAACAACT GCTGACATCG AGCTTGCTAC AAGGGACTTT 3991 CCGCTGGGGA CTTTCCAGGG AGGCGTGGCC TGGCCGGGAC TGGGGAGTGG CGACCCCTCA GATGCTGCAT 4061 ATAAGCAGCT GCTTTTTGCC TGTACTGGGT CTCTCTGGTT AGACCAGATC TCAGCCTGGG AGCTCTCTGG 4131 CTAACTAGGG AACCCACTGC TTAAGCCTCA ATAAAGCTTG CCTTGAGTGC TTCpAGTAGT GTGTGCCCGT 4201 CTGTTGTGTG ACTCTGGTAA CTAGAGATCC CTCACACCCT.TTTAGTCAGT CTGGAAAATC TCTAGCACCC 4271 CCCAGGAGGT AGAGGTTGCA GTGAGCCAAG ATCGCGCCAC TGCATTCCAG CCTGGGCAAG AAAACAAGAC 4341 TGTCTAAAAT AATAATAATA ACTTAAGGGT ATTAAATATA TTTATACATG CAGGTCATAA AAATATATAT 4411 ATTTGGGCTG GGCGCAGTGG CTCACACCTG CGCCCGGCCC TTTGGGACGC CGAGGCACGT GGATCACCTG 4481 AGTTTGGGAG TTCCAGACCA GCCTGACCAA CATGGAGAAA CCCCTTCTCT GTGTATTTTT AGTAGATTTT 4551 ATTTTATGTG TATTTTATTC ACAGGTATTT CTGGAAAACT GAAACTGTTT TTCCTCTACT CTCATACCAC 4621 AAGAATCATC AGCACAGAGG AAGACTTCTG TGATCAAATG TGGTGGGAGA GGGAGGTTTT CACCAGCACA 4691 TGAGCAGTCA CTTCTCCCGC AGACTCCGCG CGTGTCCTTC GCTTCAGTTC CAACACCCCC TGCCTGGAGA 4761 GAGGTCAGAC CACAGGGTGA GGGCTCACTC CCCAACACAT AAACACCCAA GACATAAACA CCCAACAGGT 4831 CCACCCCGCC TGCTGCCCAG GCAGAGCCGA TTCACCAAGA CGGGAATTAG GATAGAGAAA GAGTAAGTCA 4901 CACAGAGCCG GCTGTGCGGG AGAACGGACT TCTATTATGA CTCAAATCAG TCTCCCCAAG CATTCGGGGA 4971 TCAGAGTTTT TAAGGATAAC TTACTGTCTA GGGGGCCACT GAGTTGGAGA TGAAAGCCTA GGGACTCCAA 5041 GCTGTCCTTT TGCGCCGAGT CAGTTCCTGG GTGGGGGCCA CAAGATCGGA TGAGCCAGTT TATCAATCCG 5111 GGCGTGCCAC CTGATCCATG GAGTGCAGGG TCTGCAAAAT ATCTCAAGCA CTGATTGATC TTAGGTTIZ'A 5181 CAATAGTGAT CT[ACCCCAG GAACAATTTG GGGAAGGTCA GAATCTTCTA GCCTGTAGCT CCATGACTCC 5251 TAAACCATAA TTTCTTTTTT GTlTTTTTTT TTTTATITIT GAGACAGGGT CTCACTCTGT CACCTAGGCT 5321 GGACTGCAGT GCTGCAATCA CAGCTCACTG CAGCCCCTAG AGCGCCCGCC ACCGCGGTGG AGCTCCAATT 5391 CCCCCTATAG TGAGTCGTAT TACAATTCAC TGGCCCTCGT TTTACAACGT CGTGACTGGG AAAACCCTGG 5461 CGTTACCCAA CTTAATCGCC TTCCAGCACA TCCCCCTTTC GCCAGCTCCC CTAATAGCCA AGAGGCCCCC 5531 ACCCATCGCC CTTCCCAACA CTTCCCCAGC CTGAATGCCG AATGGCCCCA AATTCTAAAC CTTAATATTT 5601 TGTTAAAATT CGCGTTAAAT TTTTCTTAAA TCACCTCATT TTTTAACCAA TAGGCCGAAA TCGGCAAAAT 5671 CCCTTATAAA TCAAAAGAAT AGACCCAGAT AGGGTTGACT GTTGTTCCAC TTTGGAACAA CACTCCACTA 5741 TTAAAGAACG TGGACTCCAA CGTCAAAGGG CCAAAAACCG TCTATCACGG CGATCCCCCA CTACGTGAAC 5811 CATCACCCTA ATCAAGTTTT TTCGGGTCCA GCTGCCCTAA AGCACTAAAT CGGAACCCTA AAGCCAGCCC 5881 CCGATTTAGA GCTTGACCGG GAAACCCGGC GAACCTGGCC AGAAAGGAAG GGAAGAAAGC GAAAGGAGCG 5951 GGCGCTAGGG CCCTGGCAAG TGTAGCGGTC ACGCTGCGCG TAACCACCAC ACCCGCCCCG CTTAATCCGC 6021 CCCTACAGGG CGCGTCCCAC GTGGCACTTT TCGCGGAAAT CTGCCCGGAA CCCCTATTTG TTTATTTTTC 6091 TAAATACATT CAAATATGTA TCCGCTCATG AGACAATAAC CCTGATAAAT GCTTCAATAA TATTCAAAAA FIG. 11 D

III III a IIOI DID IIO 1101 ID III DII IDI DID IID IID IIID II DI IIi

III III a IIOI DID IIO 1101 ID III DII IDI DID IID IID IIID II DI IIi 19) United States III III a IIOI DID IIO 1101 ID III DII IDI DID IID IID IIID II DI IIi US 20090162400A1 (12) Patent Application Publication Al Powell et al. (43) Pub. Date: Jun. 25, (54) COMPOSITIONS

More information

US 20070106714A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2007/0106714 A1 Rothbarth (43) Pub. Date: May 10, 2007

US 20070106714A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2007/0106714 A1 Rothbarth (43) Pub. Date: May 10, 2007 US 20070106714A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: Rothbarth (43) Pub. Date: May 10, 2007 (54) METHOD AND SYSTEM USING AN (60) Provisional application No. 60/417,448,?led

More information

How to Read a Biotech Patent

How to Read a Biotech Patent CHAPTER 4.2 How to Read a Biotech Patent Carol Nottenburg, Principal/Patent Lawyer, Cougar Patent Law, U.S.A. ABSTRACT This chapter provides an annotated description of a sample U.S. patent. The U.S. patent

More information

pcas-guide System Validation in Genome Editing

pcas-guide System Validation in Genome Editing pcas-guide System Validation in Genome Editing Tagging HSP60 with HA tag genome editing The latest tool in genome editing CRISPR/Cas9 allows for specific genome disruption and replacement in a flexible

More information

(21) Appl. No.: 09/120,044

(21) Appl. No.: 09/120,044 US 20010014332A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2001/0014332 A1 MINETTI et al. (43) Pub. Date: Aug. 16, 2001 (54) MODIFIED IMMUNOGENIC PNEUMOLYSIN COMPOSITIONS

More information

Recherche und Beratung

Recherche und Beratung 1. Basic aspects of the patent 2. Biotechnology - Protection of Plant Inventions 3. Patent Searching in Espacenet 4. Advanced Patent Searching 5. Biosequences in Patents 1 1. Basic aspects of the patent

More information

(12) United States Patent (10) Patent N0.: US 7,068,424 B1 Jennings et al. (45) Date of Patent: Jun. 27, 2006

(12) United States Patent (10) Patent N0.: US 7,068,424 B1 Jennings et al. (45) Date of Patent: Jun. 27, 2006 US007068424B1 (12) United States Patent (10) Patent N0.: US 7,068,424 B1 Jennings et al. (45) Date of Patent: Jun. 27, 2006 (54) MULTIPLE PULSE GENERATION 6,141,127 A * 10/2000 Boivin et a1...... 398/92

More information

Why is FTO important?

Why is FTO important? Antibodies, Patents and Freedom to Operate: The Monoclonal Maze Timothy J. Shea, Jr. Director Tracy Muller Associate Sterne, Kessler, Goldstein & Fox P.L.L.C. 4 th Annual Antibody Therapeutics Conference

More information

1 2 3 4 5 6 Figure 4.1: Gel picture showing Generation of HIV-1subtype C codon optimized env expressing recombinant plasmid pvax-1:

1 2 3 4 5 6 Figure 4.1: Gel picture showing Generation of HIV-1subtype C codon optimized env expressing recombinant plasmid pvax-1: Full-fledged work is in progress towards construction and cloning of codon optimized envelope with subsequent aims towards immunization of mice to study immune responses. 1 2 4 5 6 Figure 4.1: Gel picture

More information

i Sampling Results 1 Batch (12) United States Patent Ravid et a]. US 8,706,742 B1 Apr. 22, 2014 (60) /20 Consistency 60 Validation /

i Sampling Results 1 Batch (12) United States Patent Ravid et a]. US 8,706,742 B1 Apr. 22, 2014 (60) /20 Consistency 60 Validation / US008706742B1 (12) United States Patent Ravid et a]. (10) Patent N0.: (45) Date of Patent: US 8,706,742 B1 Apr. 22, 2014 (54) (75) (73) (21) (22) (63) (60) (51) (52) (58) SYSTEM FOR ENHANCING EXPERT-BASED

More information

Introduction to Bioinformatics 3. DNA editing and contig assembly

Introduction to Bioinformatics 3. DNA editing and contig assembly Introduction to Bioinformatics 3. DNA editing and contig assembly Benjamin F. Matthews United States Department of Agriculture Soybean Genomics and Improvement Laboratory Beltsville, MD 20708 matthewb@ba.ars.usda.gov

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DEVELOPMENT AND MANUFACTURE OF LENTIVIRAL VECTORS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DEVELOPMENT AND MANUFACTURE OF LENTIVIRAL VECTORS European Medicines Agency Evaluation of Medicines for Human Use London, 26 May 2005 CHMP/BWP/2458/03 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DEVELOPMENT AND MANUFACTURE OF LENTIVIRAL

More information

(12) United States Patent

(12) United States Patent (12) United States Patent US006934727B2 (10) Patent N0.: US 6,934,727 B2 Berkowitz et al. (45) Date of Patent: *Aug. 23, 2005 (54) DYNAMIC SYNCHRONIZATION OF TABLES 6,052,695 A * 4/2000 Abe et a1......

More information

Structure and Function of DNA

Structure and Function of DNA Structure and Function of DNA DNA and RNA Structure DNA and RNA are nucleic acids. They consist of chemical units called nucleotides. The nucleotides are joined by a sugar-phosphate backbone. The four

More information

Carla L. Endres, PhD USU-Eastern-Blanding BLT 108 639 West 100 South Blanding Utah 84511 Office: 435.678.8209 Email: carla.endres@usu.

Carla L. Endres, PhD USU-Eastern-Blanding BLT 108 639 West 100 South Blanding Utah 84511 Office: 435.678.8209 Email: carla.endres@usu. Carla L. Endres, PhD USU-Eastern-Blanding BLT 108 639 West 100 South Blanding Utah 84511 Office: 435.678.8209 Email: carla.endres@usu.edu E D U C A T I O N Post doctoral Fellow, Oregon Regional Primate

More information

Coding sequence the sequence of nucleotide bases on the DNA that are transcribed into RNA which are in turn translated into protein

Coding sequence the sequence of nucleotide bases on the DNA that are transcribed into RNA which are in turn translated into protein Assignment 3 Michele Owens Vocabulary Gene: A sequence of DNA that instructs a cell to produce a particular protein Promoter a control sequence near the start of a gene Coding sequence the sequence of

More information

(12) United States Patent (16) Patent N6.= US 6,198,814 B1 Gill (45) Date of Patent: Mar. 6, 2001

(12) United States Patent (16) Patent N6.= US 6,198,814 B1 Gill (45) Date of Patent: Mar. 6, 2001 US006198814B1 (12) United States Patent (16) Patent N6.= Gill (45) Date of Patent: Mar. 6, 2001 (54) SYSTEM AND METHOD FOR ENTERING 5,621,790 * 4/1997 Grossman 6161...... 379/266 CALL OUTCOME RECORDS IN

More information

Mouse ES Cell Nucleofector Kit

Mouse ES Cell Nucleofector Kit page 1 of 7 Mouse ES Cell Nucleofector Kit for Mouse Embryonic Stem Cells Cell type Origin Cells derived from mouse blastocysts. Morphology Round cells growing in clumps. Important remarks! 1. This protocol

More information

(12) United States Patent Mine et al.

(12) United States Patent Mine et al. US008612715B2 (12) United States Patent Mine et al. (10) Patent N0.: (45) Date of Patent: US 8,612,715 B2 *Dec. 17, 2013 (54) (75) (73) (21) (22) (65) (63) (51) (52) (58) STORAGE SYSTEM AND UTILIZATION

More information

Lessons from the Stanford HIV Drug Resistance Database

Lessons from the Stanford HIV Drug Resistance Database 1 Lessons from the Stanford HIV Drug Resistance Database Bob Shafer, MD Department of Medicine and by Courtesy Pathology (Infectious Diseases) Stanford University Outline 2 Goals and rationale for HIVDB

More information

LabGenius. Technical design notes. The world s most advanced synthetic DNA libraries. hi@labgeni.us V1.5 NOV 15

LabGenius. Technical design notes. The world s most advanced synthetic DNA libraries. hi@labgeni.us V1.5 NOV 15 LabGenius The world s most advanced synthetic DNA libraries Technical design notes hi@labgeni.us V1.5 NOV 15 Introduction OUR APPROACH LabGenius is a gene synthesis company focussed on the design and manufacture

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions

Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions Document issued on: September 14, 2007 The draft of this guidance document was

More information

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation -Optimal strategies to a successful mirna research project Optimal strategies to a successful mirna research

More information

Bio 102 Practice Problems Genetic Code and Mutation

Bio 102 Practice Problems Genetic Code and Mutation Bio 102 Practice Problems Genetic Code and Mutation Multiple choice: Unless otherwise directed, circle the one best answer: 1. Beadle and Tatum mutagenized Neurospora to find strains that required arginine

More information

III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi

III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi III III a IIOI OlD III OlD IIO 1101 010 III DID III 100 III0 II uii IIi US oi ^^_._.,o.i ^,) United States (12) Patent Application Publication Buyse et al. (43) Pub. Date: Oct. 28, (54) HPV POLYEPITOPE

More information

Data Mining Analysis of HIV-1 Protease Crystal Structures

Data Mining Analysis of HIV-1 Protease Crystal Structures Data Mining Analysis of HIV-1 Protease Crystal Structures Gene M. Ko, A. Srinivas Reddy, Sunil Kumar, and Rajni Garg AP0907 09 Data Mining Analysis of HIV-1 Protease Crystal Structures Gene M. Ko 1, A.

More information

Integrated Protein Services

Integrated Protein Services Integrated Protein Services Custom protein expression & purification Version DC04-0012 Expression strategy The first step in the recombinant protein generation process is to design an appropriate expression

More information

AAV specific issues pertaining to vector shedding in gene therapy clinical trials. Samuel Wadsworth Genzyme Corporation

AAV specific issues pertaining to vector shedding in gene therapy clinical trials. Samuel Wadsworth Genzyme Corporation AAV specific issues pertaining to vector shedding in gene therapy clinical trials Samuel Wadsworth Genzyme Corporation Workshop objectives Assess the impact of vector design on shedding (studies) Review

More information

Application of Neutralization Fingerprinting in Antibody Epitope Prediction and Delineating Antibody Recognition in HIV-1 Sera

Application of Neutralization Fingerprinting in Antibody Epitope Prediction and Delineating Antibody Recognition in HIV-1 Sera Application of Neutralization Fingerprinting in Antibody Epitope Prediction and Delineating Antibody Recognition in HIV-1 Sera Gwo-Yu Chuang Structural Bioinformatics Section Vaccine Research Center/NIAID/NIH

More information

Genomes and SNPs in Malaria and Sickle Cell Anemia

Genomes and SNPs in Malaria and Sickle Cell Anemia Genomes and SNPs in Malaria and Sickle Cell Anemia Introduction to Genome Browsing with Ensembl Ensembl The vast amount of information in biological databases today demands a way of organising and accessing

More information

CCR Biology - Chapter 9 Practice Test - Summer 2012

CCR Biology - Chapter 9 Practice Test - Summer 2012 Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible

More information

Becker Muscular Dystrophy

Becker Muscular Dystrophy Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency

More information

MEF Starter Nucleofector Kit

MEF Starter Nucleofector Kit page 1 of 7 MEF Starter Nucleofector Kit for Mouse Embryonic Fibroblasts (MEF) MEF display significant phenotypic variations which depend on the strain, the genetic background of the mice they are isolated

More information

6,011,024 Jan. 4, 2000

6,011,024 Jan. 4, 2000 United States Patent [19] Reed et al. US006011024A [11] Patent Number: [45] Date of Patent: 6,011,024 Jan. 4, 2000 [54] STEROID SULPHATASE INHIBITORS [75] Inventors: Michael John Reed, London; Barry Victor

More information

The Body s Defenses CHAPTER 24

The Body s Defenses CHAPTER 24 CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,

More information

Integrated Protein Services

Integrated Protein Services Integrated Protein Services Custom protein expression & purification Last date of revision June 2015 Version DC04-0013 www.iba-lifesciences.com Expression strategy The first step in the recombinant protein

More information

(12) United States Patent

(12) United States Patent US008590045B2 (12) United States Patent Niemela et al. (io) Patent No.: US 8,590,045 B2 (45) Date of Patent: Nov. 19, 2013 (54) MALWARE DETECTION BY APPLICATION MONITORING (75) Inventors: Jarno Niemela,

More information

HUMAN GENETIC TESTING PATENTS : ELIGIBILITY AND ENFORCEMENT

HUMAN GENETIC TESTING PATENTS : ELIGIBILITY AND ENFORCEMENT HUMAN GENETIC TESTING PATENTS : ELIGIBILITY AND ENFORCEMENT FRENCH APPROACH DENISE HIRSCH HEAD OF IP THE ENVIRONNENT Patentability of living organism was a public debate in France focusing on ethical issues

More information

Sickle cell anemia: Altered beta chain Single AA change (#6 Glu to Val) Consequence: Protein polymerizes Change in RBC shape ---> phenotypes

Sickle cell anemia: Altered beta chain Single AA change (#6 Glu to Val) Consequence: Protein polymerizes Change in RBC shape ---> phenotypes Protein Structure Polypeptide: Protein: Therefore: Example: Single chain of amino acids 1 or more polypeptide chains All polypeptides are proteins Some proteins contain >1 polypeptide Hemoglobin (O 2 binding

More information

TOWARDS AN HIV VACCINE

TOWARDS AN HIV VACCINE why is it so hard to make an HIV vaccine and where are we now? Neal Nathanson, MD Emeritus Professor Department of Microbiology University of Pennsylvania School of Medicine 1 Estimated number of persons

More information

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network

More information

a. Ribosomal RNA rrna a type ofrna that combines with proteins to form Ribosomes on which polypeptide chains of proteins are assembled

a. Ribosomal RNA rrna a type ofrna that combines with proteins to form Ribosomes on which polypeptide chains of proteins are assembled Biology 101 Chapter 14 Name: Fill-in-the-Blanks Which base follows the next in a strand of DNA is referred to. as the base (1) Sequence. The region of DNA that calls for the assembly of specific amino

More information

(12) United States Patent Kasamatsu et al.

(12) United States Patent Kasamatsu et al. US007872768B2 (12) United States Patent Kasamatsu et al. (10) Patent N0.: (45) Date of Patent: US 7,872,768 B2 Jan. 18, 2011 (54) IMAGE FORMING APPARATUS CAPABLE OF NOTIFYING USER OF EXIT STATUS OF DISCHARGED

More information

2006 7.012 Problem Set 3 KEY

2006 7.012 Problem Set 3 KEY 2006 7.012 Problem Set 3 KEY Due before 5 PM on FRIDAY, October 13, 2006. Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. Which reaction is catalyzed by each

More information

(12) United States Patent D0dd et al.

(12) United States Patent D0dd et al. (12) United States Patent D0dd et al. US006907531B1 (10) Patent N0.: (45) Date of Patent: US 6,907,531 B1 Jun. 14, 2005 (54) METHOD AND SYSTEM FOR IDENTIFYING, FIXING, AND UPDATING SECURITY VULNERABILITIES

More information

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope Viruses Chapter 10: Viruses Lecture Exam #3 Wednesday, November 22 nd (This lecture WILL be on Exam #3) Dr. Amy Rogers Office Hours: MW 9-10 AM Too small to see with a light microscope Visible with electron

More information

Production of antigens and antibodies in plants: alternative technology?

Production of antigens and antibodies in plants: alternative technology? Production of antigens and antibodies in plants: alternative technology? George Lomonossoff John Innes Centre Norwich, UK ECOPA, Alicante 29 th Sept. 2006 Why use Plants as Biofactories? Produce large

More information

Chapter 18: Applications of Immunology

Chapter 18: Applications of Immunology Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing

More information

Recombinant DNA Technology

Recombinant DNA Technology Recombinant DNA Technology Dates in the Development of Gene Cloning: 1965 - plasmids 1967 - ligase 1970 - restriction endonucleases 1972 - first experiments in gene splicing 1974 - worldwide moratorium

More information

Enhanced Vessel Traffic Management System Booking Slots Available and Vessels Booked per Day From 12-JAN-2016 To 30-JUN-2017

Enhanced Vessel Traffic Management System Booking Slots Available and Vessels Booked per Day From 12-JAN-2016 To 30-JUN-2017 From -JAN- To -JUN- -JAN- VIRP Page Period Period Period -JAN- 8 -JAN- 8 9 -JAN- 8 8 -JAN- -JAN- -JAN- 8-JAN- 9-JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- 8-JAN- 9-JAN- -JAN- -JAN- -FEB- : days

More information

Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors

Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors This document is scheduled to be published in the Federal Register on 01/08/2016 and available online at http://federalregister.gov/a/2016-00149, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

(http://genomes.urv.es/caical) TUTORIAL. (July 2006)

(http://genomes.urv.es/caical) TUTORIAL. (July 2006) (http://genomes.urv.es/caical) TUTORIAL (July 2006) CAIcal manual 2 Table of contents Introduction... 3 Required inputs... 5 SECTION A Calculation of parameters... 8 SECTION B CAI calculation for FASTA

More information

Patent issues in Industrial Biotech:

Patent issues in Industrial Biotech: Patent issues in Industrial Biotech: Nucleic Acids, Life Forms & Natural Products Konrad Sechley PhD, Vancouver, Canada 18 April, 2016 OVERVIEW Gene patenting Life Forms & Natural Products Conclusions

More information

7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology)

7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology) 7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology) Students should fulfill a total of 44 credit hours: 1- Compulsory courses: 14 credit hours. 1504801, 1504802, 1504803,

More information

Analysis One Code Desc. Transaction Amount. Fiscal Period

Analysis One Code Desc. Transaction Amount. Fiscal Period Analysis One Code Desc Transaction Amount Fiscal Period 57.63 Oct-12 12.13 Oct-12-38.90 Oct-12-773.00 Oct-12-800.00 Oct-12-187.00 Oct-12-82.00 Oct-12-82.00 Oct-12-110.00 Oct-12-1115.25 Oct-12-71.00 Oct-12-41.00

More information

Immunology Ambassador Guide (updated 2014)

Immunology Ambassador Guide (updated 2014) Immunology Ambassador Guide (updated 2014) Immunity and Disease We will talk today about the immune system and how it protects us from disease. Also, we ll learn some unique ways that our immune system

More information

NS5B Sequencing and Phenotypic Resistance Assays for HCV Subtypes 1a and 1b

NS5B Sequencing and Phenotypic Resistance Assays for HCV Subtypes 1a and 1b NS5B Sequencing and Phenotypic Resistance Assays for HCV Subtypes 1a and 1b 5th Intl. Workshop on Hepatitis C Resistance & New Compounds Jacqueline Reeves NS5B Resistance Assays for HCV Subtypes 1a and

More information

(12) United States Patent (10) Patent No.: US 8,253,226 B2 Oguri (45) Date of Patent: Aug. 28, 2012

(12) United States Patent (10) Patent No.: US 8,253,226 B2 Oguri (45) Date of Patent: Aug. 28, 2012 US008253226B2 (12) United States Patent (10) Patent No.: US 8,253,226 B2 Oguri (45) Date of Patent: Aug. 28, 2012 (54) ELECTRONIC PARTS, AND METHOD FOR (56) References Cited ARRANGING SHIELDING CASE AND

More information

Microarray analysis of viral infections

Microarray analysis of viral infections Microarray analysis of viral infections Dipl. Biol. Department of Virology Bernhard Nocht Institute for Tropical Medicine Berhard Nocht Institut für Tropenmedizin Possible investigations of viral infections

More information

GENEWIZ, Inc. DNA Sequencing Service Details for USC Norris Comprehensive Cancer Center DNA Core

GENEWIZ, Inc. DNA Sequencing Service Details for USC Norris Comprehensive Cancer Center DNA Core DNA Sequencing Services Pre-Mixed o Provide template and primer, mixed into the same tube* Pre-Defined o Provide template and primer in separate tubes* Custom o Full-service for samples with unknown concentration

More information

81121228181116 1 1 1 (

81121228181116 1 1 1 ( US008483073B2 (12) Ulllted States Patent (10) Patent N0.: US 8,483,073 B2 Ishikawa et al. (45) Date of Patent: Jul. 9, 2013 (54) TEST APPARATUS AND TEST METHOD 2003/0012141 A1 * l/2003 Gerrevink..... 370/250

More information

State Annual Report Due Dates for Business Entities page 1 of 10

State Annual Report Due Dates for Business Entities page 1 of 10 State Annual Report Due Dates for Business Entities page 1 of 10 If you form a formal business entity with the state, you may be required to file periodic reports on the status of your entity to preserve

More information

(12) United States Patent Okazaki et al.

(12) United States Patent Okazaki et al. US008401702B2 (12) United States Patent Okazaki et al. (10) Patent N0.: (45) Date of Patent: US 8,401,702 B2 Mar. 19, 2013 (54) ROBOT, AND CONTROL APPARATUS, CONTROL METHOD, AND CONTROL PROGRAM FOR ROBOT

More information

Guidance. 2. Definitions. 1. Introduction

Guidance. 2. Definitions. 1. Introduction Work with naked DNA or RNA (including oligonucleotides, sirna, mirna, sequences that code for highly biologically active molecules and full length viral genomes) Guidance 1. Introduction The following

More information

US006282278B1 (12) United States Patent. (10) Patent N0.: US 6,282,278 B1 D0ganata et al. (45) Date 0f Patent: Aug. 28, 2001

US006282278B1 (12) United States Patent. (10) Patent N0.: US 6,282,278 B1 D0ganata et al. (45) Date 0f Patent: Aug. 28, 2001 US006282278B1 (12) United States Patent (10) Patent N0.: US 6,282,278 B1 D0ganata et al. (45) Date 0f Patent: Aug. 28, 2001 (54) UNIVERSAL CONFERENCE CONTROL 5,758,281 * 5/1998 Emery et a1...... 455/428

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS

More information

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications Product Bulletin Sequencing Software SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications Comprehensive reference sequence handling Helps interpret the role of each

More information

17 Claims, 19 Drawing Sheets EG4 SD4 {8L4 ( I; DLI Q P A. \! v,zcll. RG1 7 / l. a U ' 14 A I 1) ~ $133 .. _. _. _. T. _. _. _. /,.

17 Claims, 19 Drawing Sheets EG4 SD4 {8L4 ( I; DLI Q P A. \! v,zcll. RG1 7 / l. a U ' 14 A I 1) ~ $133 .. _. _. _. T. _. _. _. /,. US008564751B2 (12) United States Patent Nakanishi et a]. (10) Patent N0.: (45) Date of Patent: US 8,564,751 B2 Oct. 22, 2013 (54) (75) (73) ( * ) (21) (22) (86) (87) (65) (30) Apr. 17, 2009 (JP)..... 2009-101273

More information

Biological Sequence Data Formats

Biological Sequence Data Formats Biological Sequence Data Formats Here we present three standard formats in which biological sequence data (DNA, RNA and protein) can be stored and presented. Raw Sequence: Data without description. FASTA

More information

Milestones of bacterial genetic research:

Milestones of bacterial genetic research: Milestones of bacterial genetic research: 1944 Avery's pneumococcal transformation experiment shows that DNA is the hereditary material 1946 Lederberg & Tatum describes bacterial conjugation using biochemical

More information

Chapter 1800 Patent Cooperation Treaty

Chapter 1800 Patent Cooperation Treaty Chapter 1800 Patent Cooperation Treaty 1801 Basic Patent Cooperation Treaty (PCT) Principles 1802 PCT Definitions 1803 Reservations Under the PCT Taken by the United States of America 1804 [Reserved] 1805

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

Thermo Scientific DyNAmo cdna Synthesis Kit for qrt-pcr Technical Manual

Thermo Scientific DyNAmo cdna Synthesis Kit for qrt-pcr Technical Manual Thermo Scientific DyNAmo cdna Synthesis Kit for qrt-pcr Technical Manual F- 470S 20 cdna synthesis reactions (20 µl each) F- 470L 100 cdna synthesis reactions (20 µl each) Table of contents 1. Description...

More information

(12) United States Patent (10) Patent No.: US 8,229,231 B2 Cho et a1. (45) Date of Patent: Jul. 24, 2012

(12) United States Patent (10) Patent No.: US 8,229,231 B2 Cho et a1. (45) Date of Patent: Jul. 24, 2012 US008229231B2 (12) United States Patent (10) Patent No.: US 8,229,231 B2 Cho et a1. (45) Date of Patent: Jul. 24, 2012 (54) METHOD AND APPARATUS FOR ENCODING (56) References Cited AND DECODING IMAGE U.S.

More information

Lecture Outline. Introduction to Databases. Introduction. Data Formats Sample databases How to text search databases. Shifra Ben-Dor Irit Orr

Lecture Outline. Introduction to Databases. Introduction. Data Formats Sample databases How to text search databases. Shifra Ben-Dor Irit Orr Introduction to Databases Shifra Ben-Dor Irit Orr Lecture Outline Introduction Data and Database types Database components Data Formats Sample databases How to text search databases What units of information

More information

(12) United States Patent Halonen

(12) United States Patent Halonen (12) United States Patent Halonen US006334053B1 () Patent N0.: (45) Date of Patent: Dec. 25, 2001 (54) PROCEDURE AND SYSTEM FOR PROVIDING AN ANSWERING SERVICE (75) Inventor: Mikko Halonen, Oulu (Fl) (73)

More information

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Primary Source for figures and content: Eastern Campus Tortora, G.J. Microbiology

More information

Logging Application. (73) Assignee: AUDIOCODES, INC., Somerset, NJ (US)

Logging Application. (73) Assignee: AUDIOCODES, INC., Somerset, NJ (US) US 20090303 897Al (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0303897 A1 KOURETAS et al. (43) Pub. Date: Dec. 10, 2009 (54) METHOD AND APPARATUS FOR VOICE-OVER-IP CALL

More information

(54) SYSTEM AND METHOD FOR HEDGING W0 WO 00/30053 * 5/2000 AGAINST FOREIGN EXCHANGE RISK. Nusbam, David Trading the Wide World of foreign

(54) SYSTEM AND METHOD FOR HEDGING W0 WO 00/30053 * 5/2000 AGAINST FOREIGN EXCHANGE RISK. Nusbam, David Trading the Wide World of foreign (12) United States Patent Gerhard US006952683B1 (10) Patent N0.: (45) Date of Patent: Oct. 4, 2005 (54) SYSTEM AND METHOD FOR HEDGING W0 WO 00/30053 * 5/2000 AGAINST FOREIGN EXCHANGE RISK ASSoCIATED WITH

More information

17 July 2014 WEB-SERVER MANUAL. Contact: Michael Hackenberg (hackenberg@ugr.es)

17 July 2014 WEB-SERVER MANUAL. Contact: Michael Hackenberg (hackenberg@ugr.es) WEB-SERVER MANUAL Contact: Michael Hackenberg (hackenberg@ugr.es) 1 1 Introduction srnabench is a free web-server tool and standalone application for processing small- RNA data obtained from next generation

More information

(12) United States Patent (10) Patent N0.: US 8,695,377 B2 Bachelier et a]. (45) Date of Patent: Apr. 15, 2014

(12) United States Patent (10) Patent N0.: US 8,695,377 B2 Bachelier et a]. (45) Date of Patent: Apr. 15, 2014 USOO8695377B2 (12) United States Patent (10) Patent N0.: Bachelier et a]. (45) Date of Patent: Apr. 15, 2014 (54) PROCESS AND APPARATUS FOR THE (52) us. Cl. SEPARATION OF AIR BY CRYOGENIC USPC..... 62/644;

More information

Bioinformatics Resources at a Glance

Bioinformatics Resources at a Glance Bioinformatics Resources at a Glance A Note about FASTA Format There are MANY free bioinformatics tools available online. Bioinformaticists have developed a standard format for nucleotide and protein sequences

More information

MEF Nucleofector Kit 1 and 2

MEF Nucleofector Kit 1 and 2 page 1 of 7 MEF Nucleofector Kit 1 and 2 for Mouse Embryonic Fibroblasts (MEF) MEF display significant phenotypic variations which depend on the strain, the genetic background of the they are isolated

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

Design high specificity CRISPR-Cas9 grnas: principles and tools. Heidi Huang, PhD

Design high specificity CRISPR-Cas9 grnas: principles and tools. Heidi Huang, PhD Design high specificity CRISPR-Cas9 grnas: principles and tools Heidi Huang, PhD Webinar Agenda 1 2 3 4 Introduction of CRISPR-Cas9 grna Design Resources and Services Q&A 2 What is CRISPR? CRISPR Clustered

More information

Gene Therapy and Genetic Counseling. Chapter 20

Gene Therapy and Genetic Counseling. Chapter 20 Gene Therapy and Genetic Counseling Chapter 20 What is Gene Therapy? Treating a disease by replacing, manipulating or supplementing a gene The act of changing an individual s DNA sequence to fix a non-functional

More information

(Us) (73) Assignee: Avaya Technology Corp. Je?' McElroy, Columbia, SC (US); (21) Appl. No.: 10/413,024. (22) Filed: Apr. 14, 2003 (57) ABSTRACT

(Us) (73) Assignee: Avaya Technology Corp. Je?' McElroy, Columbia, SC (US); (21) Appl. No.: 10/413,024. (22) Filed: Apr. 14, 2003 (57) ABSTRACT US 20040202300A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0202300 A1 Cooper et al. (43) Pub. Date: Oct. 14, 2004 (54) CALL HANDLING USING NON-SPEECH CUES VIA A PERSONAL

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Interpreting Sameness of Monoclonal Antibody Products Under the Orphan Drug Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

Name Class Date. Figure 13 1. 2. Which nucleotide in Figure 13 1 indicates the nucleic acid above is RNA? a. uracil c. cytosine b. guanine d.

Name Class Date. Figure 13 1. 2. Which nucleotide in Figure 13 1 indicates the nucleic acid above is RNA? a. uracil c. cytosine b. guanine d. 13 Multiple Choice RNA and Protein Synthesis Chapter Test A Write the letter that best answers the question or completes the statement on the line provided. 1. Which of the following are found in both

More information

http://reverseproxy.companynameoom/mail

http://reverseproxy.companynameoom/mail US 20120137213A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0137213 A1 Hayler et al. (43) Pub. Date: May 31, 2012 (54) USER ROLE MAPPING IN WEB (60) Provisional application

More information

PRACTICE TEST QUESTIONS

PRACTICE TEST QUESTIONS PART A: MULTIPLE CHOICE QUESTIONS PRACTICE TEST QUESTIONS DNA & PROTEIN SYNTHESIS B 1. One of the functions of DNA is to A. secrete vacuoles. B. make copies of itself. C. join amino acids to each other.

More information

European Medicines Agency

European Medicines Agency European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein

More information

(12) United States Patent (10) Patent N0.: US 8,721,047 B2 Sakurai et a]. (45) Date of Patent: May 13, 2014

(12) United States Patent (10) Patent N0.: US 8,721,047 B2 Sakurai et a]. (45) Date of Patent: May 13, 2014 USOO8721047B2 (12) United States Patent (10) Patent N0.: US 8,721,047 B2 Sakurai et a]. (45) Date of Patent: May 13, 2014 (54) LIQUID EJECTION HEAD AND INK JET (56) References Cited PRINTING APPARATUS

More information

Gene and Chromosome Mutation Worksheet (reference pgs. 239-240 in Modern Biology textbook)

Gene and Chromosome Mutation Worksheet (reference pgs. 239-240 in Modern Biology textbook) Name Date Per Look at the diagrams, then answer the questions. Gene Mutations affect a single gene by changing its base sequence, resulting in an incorrect, or nonfunctional, protein being made. (a) A

More information

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology The Master Degree in Medical Laboratory Sciences / Clinical Microbiology, Immunology or

More information

Bio-Reagents Gene synthesis Peptide Synthesis Protein Expression Antibody Production. Life Science Products and Services

Bio-Reagents Gene synthesis Peptide Synthesis Protein Expression Antibody Production. Life Science Products and Services Bio-Reagents Gene synthesis Peptide Synthesis Protein Expression Antibody Production Life Science Products and Services Since 2002, Biomatik has provided worldwide researchers in life science discovery

More information

PCT PRACTICE International Applications Filed Prior to January 1, 2004

PCT PRACTICE International Applications Filed Prior to January 1, 2004 International Applications Filed Prior to January 1, 2004 I. Introduction The PCT (Patent Cooperation Treaty) is an international agreement for the purpose of unifying and simplifying the procedures for

More information

From Research Services and Process Development to GMP Manufacturing

From Research Services and Process Development to GMP Manufacturing From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development

More information